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Abstract 
Infection with Helicobacter pylori (H. pylori) leads to alterations of the topology and 
cellular composition of the gastric epithelium. These changes usually involve epithelial 
hyperproliferation and impaired differentiation, and may further develop into the 
gastric pathologies such as hyperplasia, atrophy and metaplasia, which are precursor 
lesions of gastric cancer. Although much is known about the organization of the 
epithelium during homeostasis, the molecular mechanisms regulating differentiation 
and turnover upon infection remain largely unknown. Recent studies have put stem cells 
in the gland base into focus and it has been demonstrated that these cells give rise to 
the whole gastric unit within one to two weeks and thus are the main drivers of gland 
repopulation. Additionally, recent studies have shown that stromal cells located in close 
proximity to the epithelial stem cell are creating the niche for this compartment and 
provide crucial factors that regulate stem cell turnover and fate decisions. Therefore, 
this thesis focuses on of Myh11+ myofibroblasts that are located beneath and between 
the epithelial gland cells and represent a central component of epithelial 
microenvironment and their responses to H. pylori infection.  
I found that during homeostasis, the myofibroblasts generate a BMP gradient along the 
gland axis with strong expression of Bmp2 in the upper part, whereas the base is 
surrounded by cells producing BMP inhibitors. Based on functional analysis with 3D 
organoid models, the BMP gradient occurs to be a main factor responsible for rapid 
differentiation of stem cells into pit surface mucous cells. Moreover, experiments led 
me to identify an auto-paracrine feed-forward BMP2 loop in epithelial cells, which 
further stabilizes BMP signaling once it is activated and induces terminal differentiation. 
Data presented in this study demonstrated a reduction of BMP signaling in H. pylori-
infected myofibroblasts. Furthermore, infection with H. pylori resulted in loss of not only 
stromal, but also epithelial Bmp2 expression. This observation was accompanied with 
increase of Interferon γ (IFNγ), which indicated a link between both pathways. 
Consistently, stimulation of organoids with IFNγ impairs BMP signaling and the BMP2 
feed-forward loop, and thereby blocks terminal differentiation.  
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Together, this study shows that the fate of a cell migrating into the surface of the gastric 
gland is determined by an induction of BMP signaling and stabilized by an auto-paracrine 
BMP signaling enhancement. Reduction of this signaling by IFNγ revealed a mechanism 
which contributes to altered cellular differentiation and development of premalignant 
epithelial alterations in the context of H. pylori infection. 
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Zusammenfassung 
Infektionen mit H. pylori führen zu Veränderungen im Aufbau und der zellulären 
Zusammensetzung des Magenepithels. Diese Veränderungen sind normalerweise mit 
einer epithelialen Hyperproliferation und einer beeinträchtigten Differenzierung 
verbunden und können sich weiter zu pathologischen Veränderungen wie der 
Hyperplasie, Atrophie und Metaplasie entwickeln, die Vorläuferläsionen von 
Magenkrebs darstellen. Obwohl viel über die Organisation des Epithels während der 
Homöostase bekannt ist, sind die molekularen Mechanismen, die die Differenzierung 
und den veränderten Zellumsatz im Kontext der Infektion regulieren, immer noch 
unbekannt. Aktuelle Studien haben Stammzellen in der Drüsenbasis in den Fokus 
gerückt, und es wurde gezeigt, dass diese Zellen innerhalb von ein bis zwei Wochen die 
Magendrüsen neu besiedeln und somit den Zellumsatz im Epithel entscheidend 
beeinflussen. Darüber hinaus haben neuere Studien gezeigt, dass Stromazellen, die sich 
in unmittelbarer Nähe der epithelialen Stammzelle befinden, die funktionelle Nische für 
dieses Kompartiment bilden und wichtige Faktoren für die Regulierung des 
Stammzellumsatzes und Differenzierung darstellen. Daher konzentriere ich mich bei 
dieser Arbeit auf die Rolle der Myh11+ Myofibroblasten, die sich sowohl unter als auch 
zwischen den Epitheldrüsenzellen befinden und eine zentrale Komponente der 
epithelialen Mikroumgebung bilden; besonderes Interesse wird dabei auf die Reaktion 
dieser Zellen im Verlauf einer Infektion mit H. pylori gelegt. 
Ich fand heraus, dass die Myofibroblasten in der Homöostase einen BMP-Gradienten 
entlang der Drüsenachse mit erhöhter Expression von Bmp2 im oberen Teil erzeugen, 
während die Drüsenbasis von Zellen umgeben ist, die Bmp-Inhibitoren produzieren. 
Basierend auf der Funktionsanalyse mit 3D-Organoidmodellen ist der Bmp-Signalweg 
ein zentraler Faktor für die rasche Differenzierung von Stammzellen in faveoläre 
mukusproduzierende Zellen. Darüber hinaus wurde ein auto- bzw. parakriner Signalweg 
gefunden, der zur Bildung von Bmp2 in Epithelzellen führt. Damit wird die Bmp-
Signalübertragung nach ihrer Aktivierung weiter stabilisiert, wodurch eine terminale 
Differenzierung induziert wird. Meine Untersuchungen Daten zeigten eine Verringerung 
des BMP-Signalwegs in H. pylori-infizierten Myofibroblasten. Darüber hinaus führte eine 
Infektion mit H. pylori nicht nur zum Verlust der stromalen, sondern auch der 
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epithelialen Bmp2-Expression. Diese Beobachtung ging mit einer Zunahme von 
Interferon γ (IFNγ) einher, was auf eine Verbindung zwischen beiden Signalwegen 
hinwies. Tatsächlich zeigten anschließende Experimente mit Organoiden, dass IFNγ den 
Bmp-Signalweg hemmt und dadurch die terminale Differenzierung blockiert. 
Zusammenfassend zeigen meine Untersuchungen, dass das Schicksal einer Zelle, die zur 
Oberfläche der Magendrüse wandert, eine Induktion des BMP-Signalwegs erfährt, der 
durch auto-parakrine BMP-Signalverstärkung zusätzlich stabilisiert wird. Die Reduktion 
dieses Signals durch IFNγ deutet auf einen Mechanismus hin, der Veränderungen in der 
zellulären Differenzierung und die Entwicklung von prämalignen epithelialen Läsionen 
im Verlauf einer H. pylori-Infektion bewirkt. 
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1 Introduction 
1.1 THE STOMACH  
1.1.1 ANATOMY AND FUNCTION 
The stomach as well as the rest of gastrointestinal track is of endodermal origin (Zorn 
and Wells 2009) and develops from the dilated part of the foregut during the fourth 
week of gestation. One week later, one side of the stomach grows faster than the other 
to create the greater curvature, which gives the stomach its characteristic shape. Three 
weeks later, the organ rotates by 90° positioning itself in its final position (Chaudhry, 
Liman, and Peterson 2019). 
Developed human stomach is located between esophagus and duodenum and consists 
of four main regions: the cardia, fundus, corpus and antrum (Figure 1.1.a). The ingested 
food gets to the stomach through cardia, which is located between esophagus and 
fundus and acts as valve closing the top of the stomach. However, multilayer 
histopathology of esophagogastric junction has shown that cardia contains features 
characteristic for both esophagus and stomach, so it is controversial to assign it to any 
of these organs (Lenglinger et al. 2012). The superior portion of the stomach is called 
fundus and is located on the left side of the cardia and has a dome-like shape (Chaudhry, 
Liman, and Peterson 2019). Following the fundus, there is the main and the largest 
portion of stomach called ‘the body’ or ‘corpus’ (San Roman and Shivdasani 2011). The 
most distal part of the stomach is the antrum, that includes the pylorus, which connects 
stomach with duodenum (Chaudhry, Liman, and Peterson 2019). Since in my work 
involves mouse models to investigate stomach changes upon Helicobacter pylori (H. 
pylori) infection, it is important to highlight the difference in the anatomy of murine 
compared to human stomach. The fundus region is absent in mice, but instead 
characteristic upper curvature is occupied by the not glandular forestomach (Figure 
1.1.b) (Kim and Shivdasani 2016). This part of the stomach is able to store well chewed 
food for one to three hours or longer and supply it for further digestion once the animal 
needs it, which is probably an adaptation to the murine lifestyle (Gartner and Pfaff 
1979).  
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Figure 1.1. Stomach regions in human and mouse. 
Representative schemes of stomach regions for human (a) and mouse (b) showing that both species 
possess corpus and antrum part of the stomach, but mouse has fore-stomach in characteristic upper 
curvature occupied by fundus in humans. Figure modified from (Burkitt et al. 2017) 
 
As a part of the gastrointestinal tract, the stomach is involved into the process of 
digestion. While absorption is mainly taking place in the small intestine, the main role 
of the stomach is to contribute to the process of digestion by providing a reservoir as 
well as by acid secretion and enzyme secretion (O'Connor and O'Morain 2014).  
Functionally, the stomach may be divided into a reservoir and a pump part. The first one 
acts in fundus and upper parts of corpus and is characterized by the ability to increase 
its volume significantly, while internal pressure stays on the same level (Cooke 1975). 
Therefore, stomach acts as a holding chamber and doses small portions of food for 
digestion and absorption into the small intestine. The lower portions of stomach, 
including antrum and lower corpus, contract in a rhythmic fashion and use peristatic 
waves to mechanically digest the food. The waves originate in gastric wall as an electric 
signal, which further induces tonic contractions and peristatic waves in proximal 
stomach propagating to the pylorus. In the lowest point of antrum, the waves increase 
their intensity until they finally reach the pyloric sphincter. Here, sufficiently liquefied 
chyme is dosed further into small intestine (Chaudhry, Liman, and Peterson 2019). 
Additionally, the stomach takes part in chemical digestion by producing pepsinogen and 
hydrochloric acid (HCl), which also create acidic environment lethal for many bacteria. 
Although main absorption is taking place in small intestine, stomach is also capable to 
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absorb amino acids, ethanol, caffeine and by production of intrinsic factor it is relevant 
for the absorption of vitamin B12 that itself takes place in the distal part of the  small 
intestine (Chaudhry, Liman, and Peterson 2019).  
 
1.1.2 MICROSCOPIC ANATOMY 
The wall in all gastrointestinal organs, including stomach, is built by four layers: serosa 
or adventitia, muscularis externa, submucosa and mucosa (Figure 1.2.a). In the stomach, 
serosa is a smooth tissue membrane, located outermost of the stomach, and which is 
known to reduce the friction from muscle movement. Next, muscularis externa is built 
by smooth muscle fibers and consists of, unlike other gastrointestinal organs, three 
layers: longitudinal, circular and additional oblique layer, which enables mechanical 
digestion (Pangtey, Kaul, and Mishra 2017). Dense connective tissue called ‘submucosa’ 
is located right next to muscularis externa. It contains blood vessels, lymphatic vessels 
and nerves, which supports the mucosa (Hsu and Lui 2019). Finally, the most inner layer 
of the stomach wall is the mucosa. The mucosa is divided into three sections: a muscle 
layer named muscularis mucosae, connective tissue layer called lamina propria and the 
epithelial glands. The main function of the muscularis mucosae and lamina propria is to 
stabilize the epithelium, not only as a scaffold but also by providing signals and factors 
(Aoki et al. 2016; Sigal et al. 2017; Stzepourginski et al. 2017). It may be crucial, because 
epithelial cells are the source of mucus, pepsinogen and HCl, which are relevant for 
proper digestion (Chaudhry, Liman, and Peterson 2019). 
The glandular epithelium is composed of a single layer of epithelial cells specialized into 
different cell types. A closer insight into the cells distribution within glands allows to 
distinguish two different gland types that are usually assigned to the main parts of the 
stomach, the antrum and the corpus (which includes not only corpus but also fundus 
part of the stomach) (Saenz and Mills 2018). The cellular composition of corpus glands 
consists of surface pit or foveolar cells, parietal cells, mucous neck cells, chief cells, 
endocrine cells and undifferentiated isthmus cells that serve as multipotent stem cell. 
Antral glands are composed of surface pit or foveolar cells, endocrine cells, progenitor 
cells as well as isthmus stem cells and deep glandular cells, which include mucous neck 
cells, chief cells and basal stem cells (Figure 1.2.b) (Willet and Mills 2016). Similar to the 
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anatomical specificity, there are also differences at the cellular level between human 
and mouse. Mouse antrum does not consist any parietal cells, whereas half of the 
human antrum glands does have some parietal cells (Choi et al. 2014). In addition, in 
human stomach these cells express gastric intrinsic factor, whereas in mouse it is 
expressed in chief cells (Levine, Nakane, and Allen 1980). 
 
Figure 1.2. Gastric cell types in antral and corpus gland. 
Representative schemes of stomach wall (a) showing four main layers of stomach and epithelial mucosa 
in antral and corpus gland unit (b) showing different cell types specification. Figure modified from (Saenz 
and Mills 2018).  
 
To understand changes in tissue structure upon H. pylori infection, it is crucial to gain 
better insight into different cell types and comprehend gland architecture in 
homeostasis. Surface mucus cells or foveolar cells are, as the name indicates, the most 
surface pit cells in gastric glands, which secrete mucus that protect stomach from gastric 
acid (Kantani-Matsumoto and Kataoka 1987). These cells are produced in the basal parts 
of the gland and migrate to the top during differentiation into pit cells. Once the cells 
reach the surface, terminal differentiation takes place, cells are culminated into necrosis 
or apoptosis and phagocytosed or extruded into gastric lumen (Ootani et al. 2003). 
Surface mucus cells may be distinguished by MUC5AC secretory mucin marker (Choi et 
al. 2014). Next, in the middle of the gland, gastric acid producing parietal cell are located 
(Yao and Forte 2003). To rapidly produce sufficient quantities of HCl, these cells are rich 
in mitochondria generating large amounts of adenosine triphosphate (ATP), which may 
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be further used by H+-K+-ATPase pump in hydrogen/potassium ions exchanged (Kopic, 
Murek, and Geibel 2010). As mentioned before, in humans, parietal cells are also the 
source of gastric intrinsic factor, which is required for the absorption of vitamin B12 
(Merchant 2018). A characteristic marker for parietal cells is the β-subunit H+-K+-ATPase 
enzyme (ATP4b) (Zhao et al. 2010). Following the parietal cells, small triangular mucous 
neck cells, which secrete an acidic fluid containing mucin proteins, can be distinguished 
(Hanby et al. 1999). In the corpus gland, these cells are interdigitated between the 
parietal cell, but in the antrum unit they are located near the base of the glands (Mills 
and Shivdasani 2011). Mucous neck cells may be identified by expression of mucin 6 
(Muc6) (Kang et al. 2005), but also by staining with lectin Griffonia Simplicifolia II (GS II) 
(Falk, Roth, and Gordon 1994). In the trans-differentiation process mucous neck cells 
migrate towards the base of the gland and convert into chief cells (Goldenring, Nam, 
and Mills 2011). Chief cells release pepsinogen, which reacts with acid produced by 
parietal cells and gets activated into the digestive enzyme pepsin (Stange et al. 2013). In 
addition, enteroendocrine cells are distributed scattered throughout the gland (Choi et 
al. 2014). These cells secrete many hormones supporting the digestion process like 
gastrin (GAST), which stimulates secretion of gastric acid (Prosapio and Jialal 2019), 
somatostatin which acts as a paracrine regulator of acid secretion (Makhlouf and 
Schubert 1990) or chromogranin A (CHGA), which promotes formation of several 
bioactive peptides (D'Amico M et al. 2014). Finally, in the base or isthmus of the gland, 
epithelial stem cells are located (Matsuo et al. 2017). These pluripotent, long-lived and 
self-renewing cells give rise to all the differentiated epithelial cells during the constant 
gland regeneration (Leushacke et al. 2013). However, antral and corpus stem cells 
populations are different. In the antrum, located at the gland base, leucine-rich repeat-
containing G-protein coupled receptor 5 (Lgr5) positive stem cells are able to repopulate 
the gland throughout their life span, but lineage tracing demonstrated relatively low 
proliferation rate of these cells (Barker et al. 2010). Moreover, recent report has showed 
that upon H. pylori infection, Lgr5+ stem cells acts not only as stem cells, but also as 
differentiated cells expressing antimicrobial genes (Sigal et al. 2019). In addition, in 
lower isthmus of antrum glands, highly proliferative axis inhibition protein 2 (Axin2) 
positive stem cells have been found, which are able to repopulate the whole gland 
within one week (Sigal et al. 2017). Moreover, many others markers have been reported 
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as antrum stem cells, including: Sox2, Lrig1, Mist1, eR1, Cckbr for isthmus region and 
Cxcr4 for both basal and isthmus part (Hata, Hayakawa, and Koike 2018). 
In contrast, Lgr5+ and Axin2+ stem cells in the corpus do not fully trace the gland (Sigal 
et al. 2017; Barker et al. 2010). Lineage tracing studies have identified Sox2+ cells 
situated in highly proliferative isthmus but also in the base of corpus gland, as potential 
stem cells (Arnold, Sarkar, et al. 2011). However, scattered location of this marker raised 
doubts whether all or only a subset of this population has stem cell properties. Further 
research associate Troy (Stange et al. 2013), Mist1 (Hayakawa et al. 2015) and Lrig1 (Choi 
et al. 2018) expressing cells with the corpus stem cell markers, but always in both 
isthmus and base gland location, suggesting that stem cells in the corpus are not only 
highly-proliferating isthmus cells but may also arise from differentiated chief cells (Nam 
et al. 2010). On the other side, recent study has reported that corpus stem cells 
populations in the isthmus and in the base are independently maintaining their gland 
compartments with the barrier created by parietal cells (Han et al. 2019). 
 
1.1.3 ORGANOIDS CULTURE 
The complex gland structure built by many different cell types, which depend on many 
different signaling pathways, encouraged scientists to create a culture model, which 
may mimic in vivo cell composition and enable to understand the mechanisms 
underlying gland homeostasis in gastric tissue. A model termed “organoids model” has 
been developed as cultured cells under appropriate culture conditions form structures, 
which resemble the features of organs they are derived from. Identification of Lgr5+ 
stem cells in the small intestine was a crucial point in developing organoids, which 
allowed infinite propagation of stem cells originating from different tissues (Sato et al. 
2009). Initially the model was obtained for small intestine, but within a short time it was 
extended to mouse (Barker and Clevers 2010) and human stomach divided into culture 
from antrum and corpus tissue (Schlaermann et al. 2016; Bartfeld et al. 2015). 
Technically the method is based on Matrigel, which at temperature below 4°C is a liquid 
but at 37°C it becomes a solidified, jelly drop. Moreover, Matrigel contains critical 
components of extracellular matrix like collagen type IV and lamin-I (Hughes, Postovit, 
and Lajoie 2010) produced by the sarcoma Engelbreth-Holm-Swarm cell line (Kleinman 
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et al. 1982), which enables embedding of epithelial glands in extracellular matrix that 
supports their growth. In addition, cultured cells require defined factors supplied with 
the medium, which mimic stem cell niche and thus provide signals for infinitive culture 
(Sato et al. 2009). In these conditions, embedded glands organized itself in structures 
similar to glands in the tissue consisting not only stem cells but also differentiated and 
dead cells, which, like in the stomach, are shed into the lumen (Sato et al. 2011). 
Furthermore, organoids culture can be stimulated with other factors which may mimic 
any desired niche or condition making it a perfect model to study gastric gland responses 
and adaptations in vitro (Co et al. 2019; Kessler et al. 2015; Broda, McCracken, and Wells 
2019).  
 
1.2 HELICOBACTER PYLORI 
1.2.1 BACTERIA AND ITS ADAPTATION 
H. pylori belongs to the class Epsilonproteobacteria, order Campylobacterales, family 
Helicobacteraceae and genus Helicobacter (Owen 1998). The genus Helicobacter was 
part of Campylobacter genus but in 1989 became an independent category with H. pylori 
as a representative (Solnick and Vandamme 2001; Vandamme et al. 1991). Today 
Helicobacter genus includes 35 species, which are gram-negative bacteria and many of 
them are characterized by resistance to mammalian stomach acid due to urease 
production and by high motility due to unipolar flagella (Dunn, Cohen, and Blaser 1997; 
Hua, Zheng, and Bow 1999). H. pylori remains the most prominent bacterium in this 
genus and colonizes over 50% of human populations, which makes it one of the most 
widespread infection in the world (Pounder and Ng 1995). However, there is a strong 
diversity in infection rates between developing countries in Africa, Asia and South 
America, where prevalence of bacteria reaches even more than 70% and industrial 
countries in Europe, North America and Australia where infection is estimated to be 
under 40% (Figure 1.3.) (Hooi et al. 2017).  
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Figure 1.3. Worldwide epidemiology of H. pylori. 
Global H. pylori prevalence of map showing large variation among regions. Figure adapted from (Hooi et 
al. 2017). 
Such a big variety may have a cause in transmission route, which is related with water, 
food, animals (Kusters, van Vliet, and Kuipers 2006) and most of all with oral and fecal 
person-to-person contact, but the exact way of transmission still remains unclear 
(Dominici et al. 1999; Escobar and Kawakami 2004; Schwarz et al. 2008). Furthermore, 
scientific data suggest that infection depends on socioeconomic status, hygiene and 
living standards (Malaty et al. 1996), mainly occurs during early childhood and without 
antibiotics treatment it may persist over time (Suerbaum and Michetti 2002).  
To become one of the most widespread infection in the world and persist in gastric acid, 
which creates barrier to pathogens (Tennant et al. 2008), H. pylori evolved by adapting 
to its environment. A functional chemotaxis machinery helps bacteria to sense a pH 
gradient in the mucus and break through to less acidic epithelial cell layer underneath 
(Schreiber et al. 2004). High motility is possible due to presence of 3-5 unipolar flagella 
on the side of the bacterium (Kim et al. 1999) as well as because of peptidoglycan 
crosslinking relaxation, which promotes its helical shape (Sycuro et al. 2010). However, 
H. pylori not only escapes from the acidic environment but also produces urease to 
convert urea into carbon dioxide and ammonia and thus neutralize acetic area around 
the bacteria (Meyer-Rosberg et al. 1996). Except adaptations associated with acidic 
environment, bacteria evolved other virulence factors, which help in colonization and 
the establishment of inflammation. One of them are outer membrane proteins (OMP) 
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separating further into Helicobacter outer porins (Hop) and Hop-related proteins (Hor) 
groups (Alm et al. 2000). This paralogous family including 33 members is involved in 
processes like importing nutrients and translating signals from the environment, but also 
plays a crucial role in adhesion to gastric epithelium by adhesins (Odenbreit et al. 1999) 
and in cytotoxin-associated gene A (CagA) translocation into cells by type IV secretion 
system (T4SS) (Ishijima et al. 2011). Moreover, occurrence of various OMP has extremely 
variable rates across different hosts and over time even within individual, which 
indicates their function in adaptation to the host or gastric niche (Odenbreit et al. 2009). 
Another H. pylori adaptation is expression of vacuolating toxin A (VacA). This toxin is 
able to form anion-selective channel in the host cell membrane resulting in large 
vacuolization and apoptosis of host cells (Yahiro et al. 2015). Recent reports suggest 
even that VacA supports bacteria to escape from phagosomes (Zheng and Jones 2003). 
However, the most prominent virulence factor is the cytotoxin-associated gene 
pathogenicity island (CagPAI). Strains carrying CagPAI induce stronger inflammatory 
response and greater risk of peptic ulcers and gastric cancer occurrence than strains 
lacking the island (Boonyanugomol et al. 2013). CagPAI encodes T4SS which acts like a 
molecular syringe and injects ADP-glycero-β-D-manno-heptose (ADP heptose), an 
lipopolysaccharides (LPS) intermediate produced in gram-negative bacteria (Pfannkuch 
et al. 2019; Stein et al. 2017). The injection results in activation of alpha kinase 1 (ALPK1) 
in the host cells, which causes TRAF-interacting protein with forkhead-associated 
domain (TIFA) phosphorylation and formation of TIFA large complex (TIFAsomes) 
(Zimmermann et al. 2017). These ADP-ALPK1-TIFA axis mediates NF-κB activation, 
interleukin 8 (IL-8) secretion and evokes innate immune response (Gall et al. 2017; 
Zimmermann et al. 2017). Most importantly, CagPAI encodes for first discovered 
bacterial oncoprotein CagA that is translocated into the cells by T4SS (Hatakeyama 
2014). Once protein reaches the host cytosol it gets phosphorylated by tyrosine kinase 
(TK), which is a domain of epidermal growth factor receptor (EGFR), activates Src 
homology region 2 domain-containing phosphatase-2 (Shp2) protooncogene and causes 
alterations in cell proliferation and morphological changes (Hatakeyama 2004). In 
addition, independently of tyrosine phosphorylation, C-terminal region of CagA is 
involved in gene transcription alternation in host cells (Baldwin et al. 2007). Moreover, 
CagA has been shown to induce gastric cancer when overexpressed in mice (Ohnishi et 
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al. 2008) and has been linked to human gastric cancer in epidemiological studies 
(Parsonnet et al. 1997). 
 
1.2.2 GASTRIC PATHOLOGIES 
Spiral-shaped bacteria present in mammalian stomach and peptic ulcers caused by 
infectious agents have been observed in the early twentieth century (Salomon 1896; 
Balfour 1906; Doenges 1939). However, the first H. pylori cultivation was established 80 
years later by Barry Marshall and Robin Warren (Marshall and Warren 1984), who not 
only isolated the bacteria but also revealed the connection between the bacteria and 
chronic gastritis (Marshall et al. 1985). These finding led to further exploration of H. 
pylori associations with gastrointestinal diseases and thus contribute to the creation of 
Correa’s cascade (Correa et al. 1975; Correa and Piazuelo 2012), which shows H. pylori-
induced gastric precancerous process (Figure 1.4.). Finally, in 1994 World Health 
Organization (WHO) classified this gastric-specific pathogen as a class I carcinogen (IARC 
1994). However, it is important to highlight that although in all H. pylori infected 
individuals gastritis will develop, only in 10% of them it progresses to gastric ulcers and 
in another 1 to 3% results in gastric cancer or mucosa associated lymphoid tissue (MALT) 
lymphoma (Wroblewski, Peek, and Wilson 2010). 
  
Figure 1.4. Correa's cascade. 
H. pylori infection of the normal gastric mucosa causes gastritis, followed by atrophy, intestinal 
metaplasia, dysplasia and gastric cancer. Bacteria is only present until intestinal metaplasia develops. 
Figure modified from (Correa and Piazuelo 2012). 
H. pylori infection induces inflammation through many different pathways in circulating 
immune cells, which increase production of inflammatory molecules like IL-1, IL-6, IL-8, 
tumor necrosis factor alpha (TNFα) and interferon gamma (IFNγ) but also in gastric 
epithelial cells, which first have contact with bacteria (McGee and Mobley 2000; Sayi et 
al. 2009). This inflammatory environment leads to gastritis and development of peptic 
ulcers disease in 10-20% infected patients (Crabtree et al. 1991). Chronic inflammation 
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induces gastric gland alteration such as increased stem cell compartment, proliferation 
of these cells and their pit-/neck-progenitors resulting in gland hyperplasia (Mills et al. 
2002; Sigal et al. 2015). Following gastritis, atrophy can occur, which is characterized by 
loss of acid producing parietal cells and chief cells (Kimura et al. 1996). The exact 
mechanism of parietal cell loss remains unknown, but it has been associated with a 
functional T4SS (Neu et al. 2002). Parietal and chief cells can be replaced by goblet, 
Paneth and enterocyte-like cells (Correa 1992) and MUC5AC and MUC6 producing 
mucous cells can be substituted by MUC2 cells (Reis et al. 1999). This switch from gastric 
epithelial cells to cells typical for intestine is named intestinal metaplasia (Correa 1992) 
and occurs in 25,7% of H. pylori infected patients with the 47.4% prevalence in those 
with gastric ulcers (Eidt and Stolte 1994). Simultaneously, spasmolytic polypeptide-
expressing metaplasia (SPEM) may develop (Schmidt et al. 1999). It describes the trans-
differentiation of basal chief cells into Muc6 and trefoil factor 2 (Tff2) expressing cells 
that are characterized by decrease of the zymogen and increase of mucous granule 
secretion (Leushacke et al. 2017; Mills and Sansom 2015). Next, neoplastic dysplasia 
appears, characterized by enlarged nuclei, cell polarity loss and gland morphology 
disruption (Rugge et al. 2000). Eventually, in 1% of the patients, as the last step of this 
series of events, intestinal type adenocarcinoma develops, mainly in the antrum region 
(Correa and Piazuelo 2012). This type of cancer consists of malignant epithelial cells with 
glandular differentiation able to infiltrate muscularis mucosae, submucosa and 
muscularis propria (Ban and Shimizu 2009). Interestingly, H. pylori which is able to 
induce the Correa’s cascade is cleared in intestinal metaplasia regions, probably due to 
presence of Paneth cells secreting different bactericidal substances (Fukuda et al. 1995).  
 
1.3 BMP SIGNALING  
1.3.1 BONE MORPHOGENETIC PROTEINS 
Bone morphogenetic proteins (BMPs) belong to large Transforming Growth Factor-β 
(TGFβ) superfamily of regulatory proteins. Although they are part of the same protein 
family and have a high sequence homology, BMP and TGFβ often play opposite roles in 
the cell regulation (Rider and Mulloy 2010). BMP was first discovered in 1965 as an 
inductor of ectopic bone formation (Urist 1965). However, it took 23 years to 
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characterize and clone the first BMPs and start their biochemical studies (Wozney et al. 
1988). Currently, BMP family includes over 20 different ligands and based on nucleotide 
and amino acid similarity or phylogenetic analysis main BMP ligands may be divided into 
subgroups: BMP2/4, BMP5/6/7/8, BMP9/BMP10, and BMP12/13/14 (GDF5/6/7) 
(Mueller and Nickel 2012). They have been reported to induce formation of cartilage 
and bone (Bandyopadhyay et al. 2006), determinate ectodermal cell fate (Munoz-
Sanjuan and Brivanlou 2002), direct neuronal development (Christiansen, Coles, and 
Wilkinson 2000), inhibit limb formation (Niswander and Martin 1993), regulate heart 
remodeling (Duan et al. 2017) and to be involved in many others processes. Moreover, 
the European Medicines Agency (EMA) approved recombinant human (rh) BMP2 for 
treatment of lumbar spine fusion and for acute tibial fractures (Arrabal et al. 2013) and 
rhBMP7 for the treatment of recalcitrant long bone non-unions (Einhorn 2003).The 
American Food and Drug Administration (FDA) approved rhBMP2 for the treatment of 
open tibial fractures (Arrabal et al. 2013). In addition, BMPs up-regulation has been 
identified in thyroid carcinoma (Meng et al. 2017), blood (Shi and Pan 2016), breast 
(Alarmo et al. 2008) and melanoma cancer (Rothhammer et al. 2005), but at the same 
time BMPs down-regulation has been reported for bladder (Kuzaka et al. 2015) and 
prostate cancer (Horvath et al. 2004). Proteins from this family have been identified as 
key regulators in such a variety of processes in all organ systems that they gained the 
“body morphogenetic proteins” name (Wagner et al. 2010). 
 
1.3.2 BMP PATHWAY 
BMPs are secreted as dimeric pro-protein complex, which is cleaved by extracellular 
protein like Furin to form a mature protein (Harrison, Al-Musawi, and Walton 2011). In 
the canonical pathway active BMPs create a homo- or heterocomplex, bind to the cell 
surface receptors and generate heterotetrameric complex with type I and type II 
serine/threonine kinase receptors (Figure 1.5.) (Heldin, Miyazono, and ten Dijke 1997). 
For BMP family there are three known type I receptors: 1A BMP receptor (BMPR-1A or 
ALK3), 1B BMP receptor (BMPR-1B or ALK6) and t1A activin receptor (ActR-1A or ALK2) 
and three type II receptors: 2 BMP receptor (BMPR-2), 2 activin receptor (ActR-2A), and 
2B activin receptor (ActR-2B) (de Caestecker 2004). The binding mechanism may vary 
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depending on ligand complex, for example BMP2/4 dimer binds to type I receptors and 
recruits type II receptors, whereas BMP6/7 bind the other way around, which results in 
activation of different pathways (Nohe et al. 2002). Once the heterotetrameric complex 
is formed, BMP type II receptor transphosphorylates type I receptor at a motif rich in 
glycine-serine (GS domain). This actives the type I receptor, which immediately 
phosphorylates receptor-regulated Smads including Smad1, Smad5 and Smad8 (Horbelt, 
Denkis, and Knaus 2012). Phosphorylated Smad1/5/8 complex associates with Smad4, 
which is a co-mediator, and translocates together into the nucleus where it acts as a 
transcription factor and regulates gene expression (Roelen et al. 2003). As a 
consequence of active BMP signaling up-regulation of target genes like Inhibitor of 
differentiation 1/2/3 (Id1/2/3/), Runt-related transcription factor (Runx) and Twist 
family BHLH transcription factor 1 (Twist1) is observed (Budna et al. 2017).  
BMP pathway may be inhibited by Smad6/7 complex that is induced by the activation of 
BMP signaling itself leading to a negative feedback inhibition of the signaling pathway 
(Moustakas, Souchelnytskyi, and Heldin 2001). Moreover, BMP signaling can be blocked 
by endogenous BMP inhibitors which either bind to BMP ligands, such as Noggin 
(Groppe et al. 2002), Chordin (CHRD) (Piccolo et al. 1996) and Gremlin (GREM) 
(Kisonaite, Wang, and Hyvonen 2016), associate with receptors and blocks ligand 
binding such as BAMBI (Onichtchouk et al. 1999) and Endoglin (Scherner et al. 2007) or 
interact with both receptors and ligands as Follistatin (Iemura et al. 1998). 
In addition, the Smad-independent non-canonical BMP signaling has been described as 
an activator of pathways such as mitogen activated protein kinase (MAPK) (Yang et al. 
2015), phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) (Chen et al. 2011), protein 
kinase C (P/kc) (Zhang 2009) and others pathways (Zhang 2017). Furthermore, it has 
been described that BMP pathway interacts with TGFβ signaling and although both are 
a part of one family, they acts as antagonists and inhibit each other effects in 
chondrocytes (Keller et al. 2011). Janus kinases/ signal transducer and activator of 
transcription (JAK/STAT) signaling has been associated with BMP4 as a co-mediator of 
non-canonical BMP signaling during megakaryopoiesis (Jeanpierre et al. 2008). 
Moreover, BMP has been also shown to interact with Wingless-Type MMTV Integration 
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Site Family (WNT) signaling and this cross-talk occurred to be both synergistic and 
antagonistic. For example, WNT has been reported to negatively regulate BMP ligands 
in the foregut (Stevens et al. 2017), but activate BMP2 expression in osteoblasts (Zhang 
et al. 2013). On the other side, BMP has been identified as suppressor as well as 
promotor of WNT signaling in colorectal cancer depending on SMAD4 and p53 status 
(Voorneveld et al. 2015). It is also not clear, which pathway is the main regulator, since 
it has been described that β-catenin acts downstream of BMPR1 but at the same time 
controls expression of Bmp4 (Soshnikova et al. 2003). Therefore, it has been suggested 
that BMP-WNT signaling interactions depend on the cellular context (Yang et al. 2016). 
 
Figure 1.5. BMP pathway. 
In canonical pathway BMP ligand dimer binds to BMP type I and II receptor complex and induces 
phosphorylation of BMP type I receptor, which further phosphorylates Smad1/5/8 and enables Smad4 
association with pSmad1/5/8. This complex is translocated into the nucleus and regulates expression of 
target genes. In non-canonical pathway BMP ligands attachment to BMP receptors induces Smad-
independent signaling. Figure modified from (Wang, Green, et al. 2014). 
 
1.3.3 ROLE IN GASTROINTESTINAL TRACT 
BMP pathway plays an important role also in gastrointestinal tract. It has been 
extensively investigated in the intestine, whereas its role in stomach is still unclear. In 
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the adult mouse intestine distribution of BMP ligands shows crypt-villus axis gradient 
with lowest activity at the bottom of the crypt, which increases to the top of the villus, 
whereas distribution of BMP inhibitor Noggin shows a reverse pattern (Qi et al. 2017; 
Haramis et al. 2004). Single-molecule RNA in situ hybridization (ISH) of BMP4 has 
revealed expression of this ligand mainly in mesenchymal cells surrounding villus and 
crypts (Haramis et al. 2004). Functionally, BMP signaling has been associated with 
suppression of intestinal proliferation and its inhibition leads to hyperproliferation and 
de novo crypt formation (Haramis et al. 2004). It has been reported that conditional 
knock-out (KO) of Bmpr1a in mesenchymal cells induces expansion of proliferating cells 
through WNT/β-catenin signaling (He et al. 2004). However, studies by Auclair and 
others (Auclair et al. 2007) as well as Qi and others (Qi et al. 2017) have shown that BMP 
regulates epithelial intestinal proliferation and stem cells compartment independently 
of WNT/β-catenin, directly through Smad4 regulation and a subset of WNT target genes 
is blocked via Smad4 independently of WNT signaling. In addition, Auclair and others 
described BMP signaling as an inducer of secretory cell differentiation (Auclair et al. 
2007). Furthermore, Qi et al revealed an inhibitory influence of BMP on Lgr5+ intestinal 
stem cells (Qi et al. 2017). This observation has been supported by organoid 
experiments, which showed an expansion of Lgr5 cells upon BMP inhibitor LDN-193189 
treatment (Tong et al. 2018). In contrast, BMP has been identified as a crucial protein 
required to establish colonic organoids from pluripotent stem cells, suggesting that BMP 
may also enhance cell growth and develop (Munera et al. 2017).  
Studies performed in the stomach confirmed hyperproliferation and hyperplasia in 
transgenic mice with Bmpr1a KO (Maloum et al. 2011) or Noggin overexpression in 
parietal cells (Takabayashi et al. 2014). Surprisingly, epithelial hyperproliferation was 
also observed upon Bmpr1a KO not only in epithelial (Maloum et al. 2011) but also 
mesenchymal cells (Roy et al. 2016). Additionally, Bmpr1a KO was associated with loss 
of parietal cells (Takabayashi et al. 2014). Despite these findings, the distribution and 
the exact function of endogenous BMP signaling molecules has not been characterized 
in detail.  
Compared to BMP signaling during homeostasis, the function of BMP signaling in 
gastrointestinal cancers appears to be more diverse. It has been shown that BMPs are 
Introduction 
24 
 
upregulated in cancer samples, including BMP2 (Park et al. 2008) and BMP7 (Aoki et al. 
2011) in gastric cancer as well as BMP4 in colorectal cancer (Yokoyama et al. 2017). 
Inhibition of BMP signaling through BMPR1A by LDN-193189 inhibitor diminished tumor 
formation of colorectal cancer cell (Yokoyama et al. 2017) while expression of BMP 
inhibitor Noggin induces dysplasia and neoplasia in gastric epithelium (Todisco 2017). 
On the other hand, BMP2 has shown frequent downregulation in colon cancer 
(Vishnubalaji et al. 2016). Moreover, its re-expression leads to inhibition of growth and 
migration and increase of chemosensitivity in human colorectal cancer cell lines as well 
as tumor suppression in mice (Vishnubalaji et al. 2016). This effect was confirmed in 
gastric cancer cells where BMP2 inhibited proliferation and induced apoptosis (Zhang et 
al. 2012). Additionally, BMP10 has been shown to be down-regulated in gastric cancer 
samples, inhibited growth and migration in gastric cancer cells and its KO promoted 
metastasis in mice (Lei et al. 2016). Thus, dual-role of BMP signaling in cancer 
progression has been suggested, and it appears that it can act as both, suppressor and 
promotor of tumorigenesis (Bach, Park, and Lee 2018). 
 
1.4 WNT SIGNALING 
WNT signaling plays a crucial role in embryonic development, but it also regulates 
important cellular functions in adult tissues such as proliferation, differentiation, 
migration and apoptosis (Ring, Kim, and Kahn 2014; Nusse 2012). Canonical WNT 
pathway is induced by glycoproteins, which interact with cell surface receptor of the 
frizzled (FZD) family (MacDonald and He 2012) and low-density lipoprotein-related 
protein (LRP) co-receptors (Wehrli et al. 2000). Absence of WNT ligands results in 
phosphorylation of β-catenin by destruction complex. This leads to proteasomal 
degradation of β-catenin and initiates TCF/LEF and Groucho complex, which induces 
histone deacetylases (HDACs) to repress target genes. If WNT ligands bind to receptors, 
phosphorylation of LRP receptor occurs and leads to activation of disheveled (DVL) and 
axin proteins, which inactivate the destruction complex, inhibiting β-catenin 
degradation (Janda et al. 2012; Li et al. 2012). Stabilized β-catenin translocates into the 
nucleus, forms a complex with TCF/LEF and disturbs  TCF/LEF-Groucho interactions 
(Potten, Wilson, and Booth 1997). This induces histone modifying co-activators and 
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results in the initiation of transcription of WNT target genes (MacDonald, Tamai, and He 
2009). These genes are known to regulate cell morphogenesis and fate (van Amerongen 
and Nusse 2009).  
In addition, non-canonical WNT pathway acts independent of β-catenin–TCF/LEF 
effectors and mainly regulates cell polarity and calcium mobilization (Veeman, Axelrod, 
and Moon 2003). Cell polarity is controlled by planar cell polarity (PCP) pathway (Axelrod 
2009). The pathway is activated by FZD receptors inducing cascade of GTPase RAC1, Ras 
homolog gene family member A (RHOA) and c-Jun N-terminal kinase (JNK), which 
further leads to rearrangements in the gene expression and cytoskeleton (Simons and 
Mlodzik 2008). Calcium mobilization is regulated by WNT-Ca2+ pathway, which starts 
from WNT-FZD activation of heterotrimeric G proteins, followed by induction of 
phospholipase C (PLC) and finally Ca2+ release from intracellular stores (De 2011).  
WNT signaling is essential for proliferation of intestinal and gastric organoids as well as 
for in vivo homeostasis of gastrointestinal epithelium (Schlaermann et al. 2016; Kuhnert 
et al. 2004; Pinto et al. 2003; Barker et al. 2010). Furthermore, in addition to WNT 
ligands, other molecules are known to enhance WNT signaling. R-spondins (RSPOs), 
which bind to Lgr4-6 receptors are able to enhance WNT signaling by preventing FZD 
ubiquitination and turnover (de Lau, Snel, and Clevers 2012). RSPO1 promotes crypt 
hyperplasia and is sufficient to culture intestinal organoids without WNT proteins, 
probably because intestinal cells produce themselves low doses of WNT molecules (Kim 
et al. 2005; Sato et al. 2009). Stromal-derived Rspo3 is expressed only in the stem cell 
niche and has been reported to induce proliferation of gastric stem cells by regulating 
WNT signaling, which leads to hyperplasia (Sigal et al. 2017). Moreover, it has been 
associated with H. pylori infection and increased anti-microbial gene expression (Sigal et 
al. 2019). In addition, withdrawn of WNT and RSPO from gastric organoids medium 
results in differentiation towards pit cells and increased amounts of parietal and ECL 
cells, suggesting its role in differentiation process (Bartfeld et al. 2015; Hayakawa et al. 
2015). 
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1.5 INTERFERON γ 
1.5.1 IFNγ PATHWAY 
IFNγ is pleiotropic cytokine, which is released by host cells in response to infections. 
There are three types of interferons: type I, which consists of alpha and beta interferons, 
type II with IFNγ and type II with interferon lambda (Lazear, Schoggins, and Diamond 
2019). The only member of type II class of interferons is encoded by different 
chromosomal locus, has an unrelated structure and interacts with other receptors than 
type I and III interferons (Gray and Goeddel 1982). Moreover, serologically IFNγ is acid-
labile, whereas type I interferons are acid-stable (DeGrado, Wasserman, and Chowdhry 
1982). IFNγ was described by Wheelock in 1965 as a product of leukocytes stimulated 
by phytohemagglutinin (Wheelock 1965). Followed this discovery other studies revealed 
that IFNγ is produced by CD4 T helper type 1 cells (Th1) and CD8 cytotoxic T lymphocyte 
(CTL) effector T-cells, natural killer (NK) and natural killer T (NKT) cells as well as antigen-
presenting cell (APC) including macrophages, dendritic cells (DCs) and B-cells (Young 
1996; Frucht et al. 2001; Harris et al. 2000). Biologically active IFNγ homodimer is binding 
to IFNγ Receptor (IFNGR) complex, which consists IFNGR1 (alpha) and IFNGR2 (beta) 
receptor chains assembled together prior to ligand attachment (Krause et al. 2002). IFNγ 
receptors are functional only as a heterodimer and cannot transduce signal individually 
(Pernis et al. 1995). Upon IFNγ binding, IFNGR complex changes its conformation and 
allows recruitment of JAK1 to IFNGR1 and JAK2 to IFNGR2 cytoplasmic domains. This is 
followed by JAK1/2 activation, which leads to second conformation change and allows 
STAT1 association with IFNγ-IFNGR complex (Blouin et al. 2016). Next, JAK1/2 
phosphorylates STAT1, which translocates to the nucleus. In the nucleus pSTAT1 binds 
to the IFNγ activated site (GAS) and regulates transcription of IFNγ associated genes 
(Decker, Kovarik, and Meinke 1997).  
In addition, IFNγ has been identified as a inductor of non-canonical pathways in the 
JAK/STAT independent process (Gil et al. 2001). This signaling may occur by activation 
of MAPKs such as PyK2, Erk1/2, and JNK (Takaoka et al. 1999), as well as the Src-family 
kinase Fyn (Uddin et al. 1997); c-Cbl, CrkL, CrkII and Vav adaptor proteins (Platanias et 
al. 1999), NF-κB transcription factor (Pfeffer 2011) and other pathways (Alsayed et al. 
2000; Wei et al. 2017). 
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IFNγ acts as an inhibitor of microbial replication as well as regulates innate and adaptive 
immune responses (Billiau and Matthys 2009; Wheelock 1965). It has been reported as 
an effector cytokine of Th1 immunity and activator of macrophages towards “M1” 
phenotype, which induce expression of pro-inflammatory cytokines, production of 
reactive nitrogen and oxygen intermediates, promotion of T-cell responses and strong 
inflammatory activity (Cherwinski et al. 1987; Hoeksema et al. 2015; Wang et al. 2018). 
In addition, IFNγ improves antigen recognition in APC by regulation of class II major 
histocompatibility complex (MHC) as well as stimulates production of many other 
cytokines and factors, which help maintain inflammation (Romieu-Mourez et al. 2007; 
Dutta, Spence, and Lampson 2003; Zhu et al. 2019). However, IFNγ does not only interact 
with immune cells. It has been described as an antiproliferating, antiangiogenic and pro-
apoptotic factor in neoplastic cells (Dighe et al. 1994; Beatty and Paterson 2001). 
Mechanism of these events still remains unclear but multiple down-stream signaling 
pathways, including PI3K/AKT and NF-κB signaling, have been reported to be involved 
(Zhang, Banik, and Ray 2007). Therefore, it has been suggested that effect of IFNγ may 
depend on tumor cells context, intensity of the signal and microenvironmental niche 
(Castro et al. 2018). Moreover, to avoid antiproliferative and pro-apoptotic IFNγ effect, 
tumor cells are losing responsive to this protein by losing the receptor of IFNγ or 
JAK/STAT component (Kaplan et al. 1998; Dighe et al. 1994). This tumor escape may 
activate alternative pathways like STAT3 which induces tumor progression and leads to 
protumorigenic effects (Evans et al. 2007). Opposite to its antiproliferative role, IFNγ has 
been reported to act as a stimulator of cells growth. In the murine pro B cells with 
blocked Stat1 function, IFNγ replaces the IL-3 pro-proliferating role (Asao and Fu 2000). 
Similar effect was observed in melanoma cells, where inhibition of Stat1 leads to 
induction of pro-proliferative IFNγ properties, suggesting that not IFNγ but Stat1 has 
anti-proliferative function (Kortylewski et al. 2004). Moreover, studies on hematopoietic 
stem cells (HSCs) has revealed that IFNγ promotes long-term repopulating HSCs 
proliferation and its in vivo KO results in lower proliferation rate (Baldridge et al. 2010). 
These results were further explored and indicated that IFNγ induces expansion of more 
differentiated multipotent progenitors of HSCs upon mice infection with Ehrlichia muri 
(MacNamara et al. 2011). Furthermore, it has been identified as an inhibitor of TGFβ and 
SMAD signaling (Ulloa, Doody, and Massague 1999) which are signals that drive 
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differentiation in the gastrointestinal epithelium. Thus, IFNγ is a major immune response 
regulator but may play diverse roles in tissue homeostasis, not only by regulating the 
immune system but also by directly interfering with epithelial stemness and 
differentiation.  
 
1.5.2 ROLE OF IFNγ IN H. PYLORI INFECTION 
IFNγ is an important cytokine within the inflammatory response to H. pylori infection. 
First, several studies have shown that mice lacking IFNγ have higher H. pylori 
colonization than wild-type mice, which indicates its protective role (Sayi et al. 2009; 
Sawai et al. 1999; Smythies et al. 2000). Antimicrobial activity of IFNγ has been 
associated directly with CagA expression in H. pylori (Zhao et al. 2011). Interestingly, a 
recent study has demonstrated how bacteria have developed mechanisms to overcome 
IFNγ-mediated antimicrobial clearance. H. pylori is inducing C-terminal tyrosine 
phosphorylation SHP2, directly through CagA, which except its tumor promoting 
properties, is a well-known inhibitor of IFNγ/STAT1 signaling (Wang, Chen, et al. 2014). 
These finding were further explained by CagA-SHP2 termination of EGFR activation, 
which led to down-regulation of MAPK as well as JAK/STAT signaling and results in 
suppression of antimicrobial human β-defensin 3 (hBD3) (Bauer et al. 2012). In addition, 
recent studies have shown that H. pylori is reducing cholesterol levels in gastric epithelial 
cells through cholesterol-a-glucosyltransferase (Cgt), which induces a degradation of 
IFNy receptors, loss of IFNγ signaling and allows bacteria to escape inflammatory 
responses (Morey et al. 2018).  
On the other side, by correlating IFNγ levels with gastric pathologies in mice infected 
with H. pylori IFNγ has been identified as a main factor driving gastric inflammation and 
infection-induced pre-neoplastic lesions (Sayi et al. 2009). IFNγ influence on gastric 
inflammation has been associated with induction of inflammatory mediators as MIP-2, 
iNOS, COX2 and interaction with NOD1 (Obonyo et al. 2002; Allison et al. 2013). 
Moreover, mice lacking IFNγ expression are not developing hyperplasia, atrophy and 
metaplasia upon H. pylori infection (Yamamoto et al. 2004). Lack of atrophy upon 
infection may be explained by apoptosis of corpus parietal cells showed upon IFNγ 
treatment in organoid model (Osaki et al. 2019). However, described anti-proliferative 
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properties of IFNγ did not clarify loss of hyperplasia upon infection in IFNγ-deficient 
mice.  Thus, IFNγ influence on gastric epithelial cells organization does not seem so 
straightforward. Despite its inhibitory effect on parietal cells (Merchant 2018), it has 
been reported that IFNγ injections induce MUC6, TFF2 and pepsinogen II expression in 
murine fundic glands (Kang et al. 2005). Addition of IFNγ to bronchial epithelial cells 
suppresses MUC5AC expression, which is the marker of pit surface mucous producing 
cells in the stomach (Oyanagi et al. 2017). Moreover, administration of IFNγ to mice 
leads to amplification of quiescence and rare gastric progenitor cells subpopulation with 
multiple lineage potential (Qiao et al. 2007). Therefore, it has been hypothesized that H. 
pylori is developing IFNγ resistance via Cgt and SHP2 to avoid its bacterial clearance and 
at the same time is inducing IFNγ-mediated gastric inflammation, but its exact influence 
on gastric epithelial organization remains unclear (Wang, Chen, et al. 2014). 
 
1.6 AIM OF THE STUDY 
The epithelium in the stomach is organized into gland units that consist of multiple cell 
types. Although the epithelium has a high proliferative activity and turnover, the 
abundance and localization of different cell types within glands is quite stable (Saenz 
and Mills 2018). The high degree of organization of the gland is based on monoclonal 
unity, which means that each cell within the gland derives from the stem cell 
compartment located in the gland base. While stem cells divide, they drive a constant 
flow of cells upwards towards the gland lumen. Within this process, cells obtain their 
differentiation phenotype and ultimately, once they reach the surface after one or two 
weeks, they terminally differentiate and are eventually shed into the lumen (Hata, 
Hayakawa, and Koike 2018). However, the mechanisms that regulate the turnover 
kinetics and dictate differentiation within the gland remain poorly understood. In the 
context of an infection of the stomach with H. pylori, the epithelial turnover kinetics, the 
distribution of cells and differentiation processes are altered (Gao et al. 2000; Murakami 
et al. 2013; Sigal et al. 2015; Sigal et al. 2019). Such changes are also reflected in 
premalignant pathological lesions that are known to be driven by infection with H. pylori, 
such as hyperplasia (increased cell number) and atrophy (loss of differentiated cells) 
(Correa and Piazuelo 2012). Previous studies in our laboratory have revealed that the 
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stem cell identity is controlled by the stem cell niche, which is composed of cells that 
surround the stem cell compartment. It has been shown in particular that a 
subpopulation of myofibroblasts that are in close proximity to the stem cells produce 
RSPO3 which induces WNT signaling in stem cells (Sigal et al. 2017). The aim of the 
presented study is to explore in detail: (1) whether and how stomach myofibroblasts 
control epithelial turnover and differentiation, (2) how their expression profile is altered 
upon infection with H. pylori and (3) whether such changes could be responsible for the 
epithelial pathologies observed upon infection.  
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2 Materials and methods 
2.1 MATERIALS 
2.1.1 MOUSE STRAINS 
Table 2.1. Mouse strains used in the study. 
Mouse strain Description Reference 
C57BL/6 Standard wild type mouse Charles River Laboratory 
IfnγRKO  KO of IFN-γ receptor gene (Huang et al. 1993) 
Lgr5CreErt2/Rosa26-
tdTomato 
Cre recombinase expression under 
Lgr5 promotor, which upon activation 
by tamoxifen induces conditional 
Rosa26-tdTomato lineage tracing. 
Mice were generated by breeding of 
Lgr5–eGFP–IRES-CreErt2 to Rosa26-
tdTomato mice. 
Lgr5–eGFP–IRES-CreErt2 
mice - (Barker et al. 2007); 
Rosa26tdTomato mice - 
(Yan et al. 2012) 
Myh11CreErt2/Rosa26-
mTmG 
Cre recombinase expression under 
Myh11 promotor, which upon 
activation by tamoxifen induces 
conditional Rosa26-mTmG lineage 
(GFP fluorescence). 
Mice were generated by breeding of 
Myh11CreErt2 to Rosa26-mTmG 
mice. 
Myh11CreErt2 mice - 
(Herring et al. 2014); 
Rosa26-mTmG mice - 
(Muzumdar et al. 2007) 
Myh11CreErt2/Rosa26-
tdTomato 
Cre recombinase expression under 
Myh11 promotor, which upon 
activation by tamoxifen induces 
conditional Rosa26-tdTomato lineage 
(Red fluorescence). 
Mice were generated by breeding of 
Myh11CreErt2 to Rosa26-tdTomato 
mice. 
Myh11CreErt2 mice - 
(Herring et al. 2014); 
Rosa26tdTomato mice - 
(Yan et al. 2012) 
 
2.1.2 BACTERIAL STRAINS 
Table 2.2. Bacterial strains used in the study. 
Strain Description Departmental 
collection number 
Antibiotics 
resistance 
Reference 
H. pylori pre-
mouse SS1 
(preMSS1, PMSS1) 
no mutation; 
wildtype 
P504 Vancomycin (Arnold, 
Lee, et al. 
2011) 
H. pylori 
PMSS1ΔcagE 
isogenic mutant 
lacking the CagE 
gene 
P551 Vancomycin and 
Chloramphenicol 
(Arnold, 
Lee, et al. 
2011) 
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2.1.3 PRIMARY CELL CULTURE REAGENTS 
Table 2.3. Commercially available primary cell culture reagents and supplements. 
Reagent Final 
concentration 
Supplier Catalog 
number  
Advanced/DMEM F12 - Invitrogen 12634-010  
B27 (50x) 1x  Invitrogen  17504044  
Bovine collagen type I  15µg/ml Gibco A1064401 
FCS - Biochrom S 0415 
fibroblast growth factor (FGF)-10  100ng/ml  Peprotech  100-26  
Gastrin 10nM  Sigma Aldrich G9145 
GlutaMax (100x) 1x  Invitrogen  35050-038  
HBSS no calcium, no magnesium - Gibco 14170088 
Hepes  0.01 M  Invitrogen  15630-056  
Liberase TL 1U/ml Sigma Aldrich 05401020001 
Matrigel, growth factor reduced, 
phenol red-free  
- BD 356231 
mouse Noggin  100ng/ml  Peprotech  250-38-1000 
murine epidermal growth factor 
(mEGF)  
50ng/ml  Invitrogen  PMG8043  
N2 (100x) 1x  Invitrogen  17502048  
Nicotinamid (NAC) 10mM Sigma Aldrich N0636 
Penicillin/Streptomycin (Pen/Strep) 100 U/ml Invitrogen  15140-122 
Sodium hypochlorite - Roth 9062.3 
4OH-Tamoxifen 800nM Sigma Aldrich H7904 
TrypLE  -  Gibco  12604021  
Y-27632 dihydrochloride monohydrate 
(ROCK-inhibitor)  
7,5µM in H2O  Sigma Aldrich Y0503  
 
Table 2.4. Primary cell culture supplements and media produced in house. 
Reagents Preparation Cell line 
ADF++ Advanced DMEM/F12 with 0.01M Hepes and  
1x GlutaMax 
- 
MSC Advanced DMEM/F12 with 10% FCS - 
RSPO1 
conditioned 
medium  
 
DMEM + 10 % FCS; selection by zeocin 
treatment (300 μg/ml; Invitrogen; #250-01) for 
5 days. Conditioned media was collected after 5 
and 10 days, centrifuged (300 x g, 15 min) and 
sterile filtrated (0.22 μm filter).  
293T HA-RSPO1-FC kindly 
provided by Prof. Hans Clevers, 
Hubrecht Institute, Utrecht, 
Netherlands  
WNT3A 
conditioned 
medium  
 
DMEM + 10 % FCS; selection by zeocin 
treatment (300 μg/ml; Invitrogen; #250-01) for 
5 days. Conditioned media was collected after 5 
and 10 days, centrifuged (300 x g, 15 min) and 
sterile filtrated (0.22 μm filter).  
293T WNT3A cell line from ATTC 
CRL-2647TM  
 
Table 2.5. Recombinant proteins added to primary cell culture. 
Recombinant 
protein 
Concentration 
[ng/ml] 
Supplier and catalog number 
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BMP2 30 R&D systems, 355-BM-010 
BMP4 30 R&D systems, 5020-BP-010 
CHRDL1 300 R&D systems, 1808-NR-050 
GREM1 500 R&D systems, 956-GR-050 
GREM2 500 R&D systems, 2069-PR-050 
IFNγ 100 R&D systems, 485-MI-100 
Noggin 100 Peprotech, 250-38-1000 
 
2.1.4 BUFFERS AND SOLUTIONS 
Table 2.6. General buffers and solutions. 
Name Preparation Supplier 
BHI medium  Ultrapure water, 36g/l BHI - 
Blocking Buffer 3% BSA, 1% Saponin, 2% Triton X-100, 0.02% Na Azide  - 
DNase/RNase 
Free Water 
- Gibco, Life 
Technologies  
FACS buffer PBS, 1% FCS, 1% HEPES, 0,5% DNase I, 3μl/ml Rock inhibitor - 
PBS: 1xDPBS 
without Ca, Mg  
-  Gibco, Life 
Technologies  
PFA (3,7-4%) 37-40g paraformaldehyde, 600ml ddH2O at 60-70°C, clear 
solution with NaOH, 100ml 10x PBS and ddH2O to 1l; pH 7.4 
- 
 
2.1.5 CHEMICALS AND REAGENTS 
Table 2.7. General chemicals and reagents. 
Name Supplier 
Bacto Brain Heart Infusion (BHI) BD Bioscience  
Bovine serum albumin (BSA), Fraction V  Life Technologies 
Brucella Broth Sigma Aldrich 
Chloramphenicol Sigma Aldrich 
Columbia agar Oxoid 
Defibrinates horse blood Oxoid 
Dithiothreitol (DTT) AppliChem 
DNase I Qiagen 
EDTA Roth 
Eosin Y solution Roth 
Ethanol Merck 
LE agarose Biozym 
Mayer’s hematoxylin solution Roth 
Paraformaldehyde (PFA) Sigma Aldrich 
Roti-Histokitt Roth 
Saponin Riedel-de Haën 
Tamoxifen Sigma Aldrich 
Triton X-100 Calbiochem 
Vancomycin   
 
MP Biomedicals 
Vectashield Vector 
Xylene Roth 
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2.1.6 COMMERCIAL KITS 
Table 2.8. Commercial kits and their application. 
Name Application Supplier Catalog 
number 
AB Power SYBR® Green 
RNA-to-CT™ 1-Step Kit 
qRT-PCR Thermo 
Scientific 
4389986 
Click-iT EdU Alexa Fluor 
594 Imaging Kit 
Proliferation assay for myofibroblasts 
culture 
Thermo 
Scientific 
C10339 
GeneJET RNA 
Purification Kit 
RNA extraction from cultured cells Thermo  
Scientific 
K0731 
HiSeq PE Rapid Cluster 
Kit v2 
RNAseq – cluster generation on flow-cell Illumina PE-402-
4002 
HiSeq Rapid SBS Kit v2 RNAseq – sequencing Illumina FC-402 
Mouse GE 4x44K v2 
Microarray Kit 
Microarrays - cRNA fragmentation and 
hybrydization 
Agilent 
Technologies 
G4846A 
Nextera XT DNA Library 
Preparation Kit 
RNAseq – library preparation Illumina FC-131 
Quick Amp Labeling Kit, 
two-color 
Microarrays – RNA labeling Agilent 
Technologies 
5190-
0444 
RNAscope 2.5 HD 
Reagent Kit- RED 
Single-molecule RNA in situ 
hybridization of tissue 
Advanced Cell 
Diagnostics 
322350 
RNeasy Mini Kit RNA extraction from the tissue Qiagen 74104 
RNeasy Plus Micro Kit RNA extraction from sorted 
myofibroblasts 
Qiagen 74034 
SMART-Seq v4 Ultra Low 
Input RNA Kit 
RNAseq – mRNA transcription and pre-
amplification 
Takara 
Clontech 
6348 
TaqMan Fast Virus 1-
Step Master Mix 
qRT-PCR Thermo 
Scientific 
4444432 
 
2.1.7 ANTIBODIES 
Table 2.9. Primary antibodies for immunofluorescence analysis. 
Protein Donor species Dilution  Supplier Catalog number 
DAPI - 1:300 Roche 10236276001 
Ki67 rabbit 1:100 Cell Signaling 
Technology 
9129S 
Lectin GS-II Alexa Fluor 647 
Conjugated 
Griffonia 
simplicifolia 
1:100 Thermo Scientific L32451 
MUC5AC mouse 1:100 Thermo Scientific MA5-12178 
Phalloidin Alexa Fluor 594 - 1:100 Thermo Scientific A12381 
Vimentin rabbit 1:100 Cell Signaling 
Technology 
5741S 
α-SMA rabbit 1:100 Abcam ab5694 
 
Table 2.10. Secondary antibodies for immunofluorescence analysis. 
Protein Reactivity Donor 
species 
Dilution  Supplier Catalog 
number 
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IgG (H+L) Alexa-Fluor 488 rabbit chicken 1:100 Thermo Scientific A21441 
IgG (H+L) Alexa-Fluor 647 rabbit chicken 1:100 Thermo Scientific A21443 
 
Table 2.11. Antibodies for flow cytometric analysis. 
Protein Donor species Dilution  Supplier Catalog number 
CD326 EpCAM-APC  mouse  1:10  Milteny Biotec  130-080-234  
Propidium iodide solution (PI) - 1:400 Sigma Aldrich P4864 
 
2.1.8 ISH PROBES 
Table 2.12. Single-molecule in situ hybridization probes. 
All probes were ordered as murine probes from Advanced Cell Diagnostics company. 
Gene name Target region  Catalog 
number 
Bmp2 854 – 2060 406661 
Bmp4 586 – 1673 401301 
Bmp6 1001 – 2389 488801 
Bmp7 2637 – 3585 407901 
Grem1 398 – 1359 314741 
Grem2 231 – 826 491631 
Chrdl1 406 – 1469 442811 
Noggin 78 – 1774 467391 
 
2.1.9 qRT-PCR PRIMERS 
Table 2.13. Primers for reverse transcription and quantitative PCR. 
Primers were designed as murine primers using BLAST online tool, obtained from Sigma Aldrich or Thermo 
Scientific and diluted to 10μM. The melting temperature was determined to 60°C. Abbreviations: For-
forward, Rev- reverse. 
Gene name Accession number Primer Sequence (5’ – 3’)  Supplier 
Axin2 NM_015732.4 For: TGACTCTCCTTCCAGATCCCA 
Rev: TGCCCACACTAGGCTGACA 
Sigma Aldrich 
Bmp1  NM_009755.3 For: TGGCCATATCCAGTCTCCCA 
Rev: TGTCGTGACGCTCAATCTCA 
Sigma Aldrich 
Bmp2 NM_007553.3 For: GACTGCGGTCTCCTAAAGGTCG 
Rev: CTGGGGAAGCAGCAACACTA 
Sigma Aldrich 
Bmp4  NM_007554.3 For: CCGGAAGCTAGGTGAGTTCG 
Rev: GGAATGGCTCCATTGGTTCCT 
Sigma Aldrich 
Bmp5  NM_007555.4 For: CAGACCCTGGTACACCTGATG 
Rev: CACAGGCACTTCCAGCTAGT 
Sigma Aldrich 
Bmp6 NM_007556.3 For: TGGGATGGCAGGACTGGAT 
Rev: TGGCATTCATGTGTGCGTTG 
Sigma Aldrich 
Bmp7 NM_007557.3 For: GGCCTGCAAGAAACATGAGC 
Rev: AGTGAACCAGTGTCTGGACG 
Sigma Aldrich 
Chga NM_007693.2 For: CAAGCACAGAGACGCAGCAG 
Rev: GGCTGGTTGGTGATTGGGTA 
Sigma Aldrich 
Chrdl1 NM_001114385.1 For: CACTGCCCCAATCGATACCC 
Rev: GGTTCTTCTGGGCACACCTTG 
Sigma Aldrich 
Gapdh NM_001289726.1 For: TCACCATCTTCCAGGAGCG Sigma Aldrich 
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Rev: AAGCAGTTGGTGGTGCAGG 
Gapdh NM_001289726.1 TaqMan Gapdh probe 
Mm99999915_g1 
Thermo Scientific 
Gast NM_010257.4 For: AGGGGACACCAAGGTGATGA 
Rev: AGCAGATTCTGGTGTCGCAG 
Sigma Aldrich 
Gif NM_008118.3 For: AAGCACAGCGCAAAAACTCC 
Rev: GCAACCCCTTCATCCAAAGG 
Sigma Aldrich 
Ifnγ NM_008337.4 TaqMan Ifnγ probe 
Mm01168134_m1 
Thermo Scientific 
Id1 NM_010495.3 For: GCTCTACGACATGAACGGCT 
Rev: AACACATGCCGCCTCGG 
Sigma Aldrich 
Irf1 NM_008390.2 For: ATCTCGGGCATCTTTCGCTT 
Rev: TCTGCATCTCTAGCCAGGGT 
Sigma Aldrich 
Itln1 NM_010584.3 For: GTTGCTACCAGAGGTTGCAGT 
Rev: AGACCATCTTGTGCCTTTGTGT 
Sigma Aldrich 
Lgr5 NM_010195.2 For: CCTACTCGAAGACTTACCCAGT 
Rev: GCATTGGGGTGAATGATAGCA 
Sigma Aldrich 
Muc5ac NM_010844.1 For: CCTGAGGGTATGGTGCTTGA 
Rev: TGTGTTGGTGCAGTCAGTAGAG 
Sigma Aldrich 
Muc6  NM_001330001.1 For: CAGCTCAACAAGGTGTGTGC 
Rev: GGTCTCCTCGTAGTTGCAGG 
Sigma Aldrich 
Rspo3 NM_028351.3 For: TTGACAGTTGCCCAGAAGGG 
Rev: CTGGCCTCACAGTGTACAATACT 
Sigma Aldrich 
Reg3b NM_011036.1 For: TCCCAGGCTTATGGCTCCTA 
Rev: GCAGGCCAGTTCTGCATCA 
Sigma Aldrich 
Reg3g NM_011260.2 For: TCTGCAAGACAGACAAGATGCT 
Rev: GCAACTTCACCTTGCACCTG 
Sigma Aldrich 
 
2.1.10 LABORATORY INSTRUMENTS 
Table 2.14. Laboratory instruments. 
Machine Application Company 
Agilent 2100 Bioanalyzer  Quality control of RNA Agilent 
BD FACSAria II flow cytometer Flow cytometry BD Bioscience 
DR/2000 Spectrophotometer Measuring optical density for 
bacteria cultivation 
HACH 
Eppendorf centrifuge 5417C Eppendorf tubes centrifugation Eppendorf 
Eppendorf centrifuge 5810R  Primary cell culture centrifugation Eppendorf 
FormaSeries II Water-Jacketed CO2 
Incubators 
Bacterial incubator Thermo Scientific 
G2565CA high-resolution laser 
microarray scanner 
Microarray Agilent Technologies 
Hera cell 150 Incubator Primary cell culture Heraeus 
HybEZ Oven Single-molecule RNA in situ 
hybridization 
Advanced Cell 
Diagnostics 
Illumina HiSeq 1500 RNAseq Illumina 
IX50-S8F inverted microscope Light microscopy Olympus 
Leica SP-8 Confocal microscopy Leica 
Logos One automat Tissue paraffin embedding Milestone 
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NanoDrop 1000 UV-Vis 
spectrophotometer 
Measurments of RNA 
concentration 
Kisker  
Olympus CKX41 and U-HGLGPS 
Fluorescence Illumination Source 
Fluorescence microscopy Olympus 
StepOnePlus Real-Time PCR System qRT-PCR Applied Biosystems 
Vibrating blade microtome VT100 S Tissue processing Leica 
 
2.1.11 SOFTWARE 
Table 2.15. Software. 
Name Application Supplier  Version 
BD FACSDiva 
software 
Flow cytometry BD Bioscience 8.0.1 
FlowJo Flow cytometry FlowJo, LLC X.0.6 
CellSensEntry Image processing Olympus - 
EndNote Literature Clarivate Analytics X8.2 
Excel Calculations, data 
processing 
Microsoft 2016 
Illustrator CS4 Image processing Adobe 14.0.0 
Image Analysis and 
Feature Extraction 
G2567AA 
Microarray analysis Agilent Technologies A.11.5.1.1 
ImageJ Image processing and 
quantification 
Open source 1.47 
Leica Application 
Suite X (LAS X) 
Confocal imaging Leica Microsystems GmbH - 
NCBI Biological databases https://www.ncbi.nlm.nih.gov/ - 
Prism Data analysis and statistic GraphPad 8 
Rosetta Resolver 
Biosoftware 
Microarray analysis Rosetta Biosoftware Build 7.2.2 
SP1.31 
StepOne Software  
 
qRT-PCR analysis Life technologies 2.3 
Volocity Image processing and 
quantification 
Improvision 6.3 
 
2.2 MURINE CELL ACQUISITION 
2.2.1 ISOLATION AND CULTURE OF GASTRIC ORGANOIDS 
To obtain organoids from murine gastric tissue, mice were sacrificed by cervical 
dislocation and stomach was separated from the mice. Next, fore-stomach was 
eliminated and glandular part was opened by the cut along the lesser curvature and 
dissected into two parts. Corpus part was removed and antrum part with transitional 
zone was taken for further preparation. It was disinfected by incubation in 5ml of 0.04% 
sodium hypochlorite diluted in phosphate buffered saline (PBS) solution for 15 minutes 
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at room temperature and washed with PBS. Tissue was then incubated on a roller 
platform for 90 minutes at room temperature in falcon tubes wrapped with aluminum 
foil containing 12ml of 0.5mM dithiothreitol (DTT) and 3mM ethylenediaminetetraacetic 
acid (EDTA) diluted in PBS to weaken the intercellular junctions and allow the release of 
the glands. After incubation, tissue was washed with PBS, placed in new, cold PBS and 
shaken vigorously. Residual tissue was removed and supernatant with released glands 
was centrifuged at 300g for 5 minutes at 4°C and resuspended in 1ml of ADF++ 
(Advanced DMEM/F12, supplemented with Hepes and Glutamax) medium. Glands 
concentration was estimated by counting their number under the microscope in 10µl 
aliquot and approximately 100 glands per well were obtained by centrifugation at 300g 
for 5 minutes at 4°C. Glands pellet was resuspended in ice cold matrigel (50µl/well), 
seeded on 24 well plate and incubated for 10 minutes at 37°C to let the matrigel solidify. 
Afterwards, 500µl/well of prewarmed medium (Table 2.16.) was added to wells to 
support organoid growth. Murine gastric organoids were cultivated at 37 °C and 5 % CO2 
and every 2-3 days medium was replaced.  
Table 2.16. Composition of gastric organoids medium. 
The final concentrations of the reagents are indicated in Table 2.3. 
Reagent Volume 
(ul) for 1ml 
medium  
B27 20 
N2 10 
NAC 2.5 
Noggin   1 
EGF* 1 
FGF 1 
Gastrin* 1 
ROCK Inhibitor 3 
WNT3a conditioned medium 500 
R-spondin 1 conditioned medium  100 
Pen/Strep 10 
ADF++ 350.5 
*(prediluted 1:10)  
For experiments with recombinant BMP2, BMP4, CHRDL1, GREM1, GREM2 and IFNγ 
proteins (Table 2.5.), organoids were cultivated for 2 days after seeding to grow and 
develop. First dose of recombinant protein was added on day 2, second on day 5 
followed by microscopic imaging and RNA extraction on day 6. Factors were added 
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directly to the wells. For experiments with RSPO and WNT withdrawal, organoids were 
cultured without RSPO and with 50% WNT from the beginning of the culture. For 
experiments with simultaneous BMP2 and IFNγ treatment, IFNγ was added followed by 
BMP2 4 hours later.  
For analyzing stemness capacity by organoid forming efficiency, after the treatment with 
recombinant proteins, organoids were passaged on day 6 and cultured further with 
normal medium without any addition of recombinant proteins. To passage the cells, 
protocol described by Schlaermann and others (Schlaermann et al. 2016) was adapted. 
Briefly, organoids were harvested by dissolving the matrigel with cold ADF++ (Advanced 
DMEM/F12, supplemented with HEPES and Glutamax). The cells were pelleted with 
centrifugation at 300g for 5 minutes at 4 °C. Next, the pellet was resuspended in 1ml 
TrypLE and incubated for 5 minutes at 37°C. A Pasteur pipet, where the opening was 
narrowed by melting the tip with the fire of a Bunsen burner, was used for pipetting up 
and down to completely dissociate organoids into single cells. Cells were then counted 
using a Neubauer Chamber and approximately 10 000 cells per well were obtained by 
centrifugation at 300g for 5 minutes at 4°C. Glands pellet was resuspended in ice cold 
matrigel (50µl/well), seeded on 24 well plate and incubated for 10 minutes at 37°C to 
let the matrigel solidify. Afterwards, 500µl/well of prewarmed medium (Table 2.16.) was 
added. 
For experiments with Lgr5 lineage tracing in organoids, glands were isolated from 
Lgr5CreErt2/Rosa26-tdTomato (Table 2.1.) mice and treated with recombinant proteins 
as described above. However, simultaneously with second dose of recombinant proteins 
on day 5, 3µM 4OH-tamoxifen was added to the culture. Next, organoids were passaged 
on day 6 as described above. 
To quantify experiments with organoids, their morphology, number and size were 
analyzed. Microscope imaging was performed with IX50-S8F inverted microscope or 
Olympus CKX41 and U-HGLGPS® Fluorescence Illumination Source Microscope. 
Numbers of organoids per well were quantified by manual counting. Diameter of 
organoids was measured using ImageJ1.47v software.  
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2.2.2 ISOLATION AND CULTURE OF MYOFIBROBLASTS 
Mouse stomach separation and tissue preparation was performed as described above. 
Antrum with transitional zone was isolated, placed on ice in PBS and taken for further 
treatment based on protocol published by Stzepourginski and others (Stzepourginski et 
al. 2017). Tissue was incubated on the shaker for 20 minutes at 37°C with 2ml of 10mM 
EDTA diluted in PBS to weaken the intercellular interactions and allow the release of 
glands. After incubation, tissue was washed four times with PBS and each time 
vigorously shaken to removed epithelial cells and obtained clear supernatant. Remained 
tissue was cut into pieces of approximately 0.3 cm2 size by using scalpel and incubated 
for 20 minutes at 37°C in a dissociation mix composed of 2ml Hank's balanced salt 
solution (HBSS), Liberase low-thermolysin (TL) (1U/ml) and DNase I (1U/ml). To improve 
dissociation, tissue pieces were gently mixed by pipetting up and down every 10 minutes 
with truncated pipet tip. After 20 minutes, supernatant was harvested and one volume 
of HBSS containing 10% fetal calf serum (FCS) was added to block enzymes digestion, 
while remaining tissue pieces were further processed with new dose of dissociation mix. 
This step was repeated three times for total time of 60 minutes. After completion of the 
three cycles, remaining tissue fragments were mechanically disaggregated on 70μm 
filter by using syringe plunger. Supernatant with cells was centrifugated at 300g for 5 
minutes at 4°C, resuspended in medium (Table 2.17.) and seeded in 6 wells on 12 well 
plate. 
Table 2.17. Composition of myofibroblasts medium. 
Reagent Volume 
(ul) for 1ml 
medium  
ROCK Inhibitor 3 
Pen/Strep 10 
MSC 1000 
 
Myofibroblasts were cultivated at 37 °C and 5 % CO2 and every 2 to 3 days the medium 
was replaced. However, to obtain pure population of myofibroblasts, cells were cultured 
for 2 passages until experiments were performed. To passage the myofibroblasts, 
medium was removed and wells were washed with PBS. Next, cells were incubated with 
1ml/well of TrypLE for 5 minutes at 37°C. After incubation, myofibroblasts were 
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collected, 1 volume of cold ADF++ was added to block TrypLE function and cells were 
centrifugated at 300g for 5 minutes at 4°C. Pellet was resuspended in medium and 
myofibroblasts were cultured further on 6-well plates.  
For experiments with recombinant BMP2 and Noggin proteins (Table 2.5.), 
myofibroblasts were cultivated for 2 days after passaging to obtain stable and confluent 
culture. First dose of recombinant protein was added on day 2, next, cells were passaged 
again on day 5 and simultaneously a second dose of recombinant protein was added, 
finally third and last dose was added on day 7 followed by RNA extraction on the next 
day. 
For experiments with myofibroblasts staining, 3µM 4OH-tamoxifen was added to 
myofibroblasts on passage 1 isolated from Myh11CreErt2/Rosa26-mTmG (Table 2.1.) 
mice. After 24 hours, cells were passaged again and seeded on collagen coated coverslip. 
To prepare collagen coated coverslip, 15mm round coverslips were sterilized, covered 
with 0,02M acetic acid and 15µg bovine collagen I, incubated for 45 minutes at 37°C and 
washed two times with warm PBS. Cells were seeded for 3 days until they reached 90-
100% confluence, washed with PBS and fixed for 20 minutes with 4% paraformaldehyde 
(PFA) at room temperature. Next, myofibroblasts were washed with PBS and blocked 
for 20 minutes with Blocking Buffer (Table 2.6.) followed by incubation with Blocking 
Buffer and Vimentin (Table 2.9.) antibody overnight, in darkness at 4°C. Next day, 
samples were washed three times with Blocking Buffer and incubated for 1 hour with 
Alexa Fluor 647 secondary antibody and 4′,6-diamidino-2-phenylindole (DAPI) (Table 
2.9. and 2.10.) diluted in Blocking Buffer. Finally, myofibroblasts were washed and 
prepared for confocal microscopy with Vectashield mounting medium (Table 2.7.) and 
nail polish to seal the cover slip.  
For proliferation assay, Click-iT EdU proliferation kit was used and assay was performed 
according to the manufacturer’s protocol. Briefly, myofibroblasts were seeded on 
coverslip and incubated overnight with 10µM 5-ethynyl-2'-deoxyuridine (EdU). Next 
day, cells were fixed with 3,7% PFA for 15 minutes, permeabilizated with 0,5% Triton X-
100 for 20 minutes and incubated with reaction cocktail provided by the company. 
Additional step for DNA staining with Hoechst 33342 was performed. 
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Myofibroblast’s staining and proliferation assay was analyzed using confocal laser 
scanning with Leica Sp8 confocal microscope. Pictures were analyzed by using 
ImageJ1.47v and Volocity 6.3. Live cell imaging software. For proliferation assay, number 
of EdU positive cells was counted, compared to DAPI positive cells and presented as 
percentage. 
 
2.2.3 FLOW CYTOMETRY OF MYH11+ CELLS 
To obtain pure population of Myh11+ myofibroblasts for RNA sequencing (RNAseq) 
analysis, fluorescence-activated cell sorting was performed with collaboration with the 
FACS Core facility of the Max Planck Institute for Infection Biology (MPIIB). 
Myh11CreErt2/Rosa26-mTmG heterozygotes were intraperitoneally injected with one 
dose of Tamoxifen (4mg per 25g body weight, diluted in 200µl corn oil) for Cre-driven 
fluorophore expression in the Myh11+ cell lineage, sacrificed 2 days later and 
myofibroblasts population was isolated as described above. Next, cells were washed 
twice with PBS, centrifuged at 300g for 5 minutes at 4°C, suspended in 400µl FACS buffer 
(Table 2.6.) and pipetted through 40μm filter into the FACS tube. Shortly before sorting, 
propidium iodide (PI) antibody (Table 2.11.) was added to stained dead cells.  
Flow cytometric analysis was performed using a BD FACSAria II flow cytometer and the 
BD FACSDiva and FlowJo vX.0.6 software. First sorting gate eliminated cell debris and 
dead cells that showed a lower level of forward scatter (FSC) in the FSC and SSC (side 
scatter) density plot. Similarly, a density plot of FSC-W (FSC-width) and FSC-H (FSC-
height), as well as SSC-W and SSC-H were used to exclude cell doublets. The fourth gate 
was used to distinguish between dead (PI positive) and alive cells. Finally, fifth gate 
separated Myh11+ myofibroblasts (green fluorescence in FITC channel) from the rest of 
the cells. Myofibroblasts were collected into the Lysis Buffer and proceed further with 
RNA extraction. 
For experiment with epithelial cell adhesion molecule (Epcam) sorting, 
Myh11CreErt2/Rosa26-tdTomato mice were sacrificed and myofibroblasts were 
isolated as described above. Next, cells were suspended in PBS with 0,5% bovine serum 
albumin (BSA) and 2mM EDTA at pH 7,2, CD326-epcam-APC mouse antibody was added 
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in dilution 1:10 and incubated 10 minutes at 4°C. After incubation, myofibroblasts were 
washed twice with FACS buffer (Table 2.6.), suspended in 400µl of this buffer and 
pipetted through 40μm filter into the FACS tube. Sorting gates were set as described 
previously, except fifth gate which separated Myh11+ myofibroblasts (red fluorescence 
caught by PE-Texas Red-A) from the Epcam+ epithelial cells (green fluorescence in APC-
A channel). 
 
2.3 H. PYLORI INFECTION 
2.3.1 CULTIVATION OF BACTERIA 
H. pylori strains were thawed from frozen stocks of the departmental collection (Table 
2.2.), diluted in 3-10ml brain heart infusion (BHI) medium, spread over the blood agar 
plate with Vancomycin or Vancomycin/Chloramphenicol and cultivated overnight at 37 
°C and 5% CO2. After 48 hours, bacteria were collected from the plate and transferred 
to falcon tube by using cotton swab. Measurements of optical density (OD) 550nm was 
performed by using spectrophotometer. Indicated concentration of bacteria was 
incubated further overnight with BHI medium and 10% FCS at 37°C, 110 revolutions per 
minute (rpm) in humid culture flask with microaerophilic conditions.  
 
2.3.2 IN VIVO INFECTION WITH H. PYLORI 
Viability of cultivated bacteria was determined by its movement and shape followed by 
OD measurements of the liquid culture. Medium and bacteria were placed in falcon 
tubes, centrifuged and bacteria at OD550 was resuspended in DMEM with 5% FCS and 
10% Brucella Broth. Mice were intragastrically infected with 5µl of bacteria suspension 
containing 108 H. pylori. 
 
2.3.3 COLONY FORMING UNIT ANALYSIS 
Serial of dilutions were performed immediately after infection to verify the bacteria 
input.100µl of bacterial suspension was diluted to 10-6, 10-7 and 10-8 and plated on blood 
agar plates in 3 replicates. After 72 hours, bacterial colonies were counted and the real 
amount of given bacteria was estimated. 
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After 2 months of infection, mice were sacrificed and small piece of corpus tissue was 
collected in previously weighed tubes with BHI medium for colony forming unit (CFU) 
analysis to estimate infection efficiency. Weight of the tissue was determined and tissue 
was homogenized in 400µl BHI medium. Next, homogenate was diluted 1:5, 1:25 and 
1:125 and plated in three replicates for each dilution on blood agar plates. Culture was 
cultivated at 37 °C and 5% CO2 for 72h and the obtained bacterial colonies were counted. 
Dilution with the least varied numbers of colonies for each tissue was chosen and 
average from three replicates was calculated. The result was normalized and the 
number of bacteria was calculated as CFUs per gram of stomach tissue.   
 
2.4 TISSUE PROCESSING AND MICROSCOPY 
For tissue collection, the fore-stomach was removed and the glandular stomach was 
opened along the lesser curvature and flattened on paper. Stomach contents were 
removed and tissue was divided into three parts along greater curvature. To minimalize 
sampling error, in each experiment, right part of the stomach was used for confocal 
microscopy analysis, central for ISH and histopathology and the left for CFU analysis. 
 
2.4.1 CONFOCAL MICROSCOPY 
For confocal microscopy, stomach sections were placed in plastics cassettes, fixed with 
4% PFA solutions for 1 hour and washed three times with PBS. Next, samples were 
embedded in 4% agarose as described previously by Sigal and others (Sigal et al. 2015). 
300µm thick longitudinal sections were prepared with vibrating blade microtome and 
permeabilized in Blocking Buffer (Table 2.6.) prior to staining. The samples were then 
stained overnight with primary antibodies (Table 2.9.), followed by 2 hours incubation 
with secondary antibodies (Table 2.10.), counterstained with DAPI for nucleus 
visualization and with phalloidin for visualization of F actin. Confocal laser scanning was 
done on Leica Sp8 confocal microscope and pictures were analyzed by using 
ImageJ1.47v and Volocity 6.3. cell imaging software.  
Quantification of fluorescent signal for TdTomato positive glands and green 
fluorescence protein (GFP) positive myofibroblasts in Myh11CreErt2/Rosa26-mTmG 
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mice treated with Tamoxifen was performed by automatic measuring of red and green 
signal in Volocity 6.3. cell imaging program and quantification of Ki67+ cells was 
performed by manual counting of Ki67 positive cells labelled with a Alexa488 conjugated 
secondary antibody per gland.  
2.4.2 HISTOPATHOLOGY 
Histopathology was performed with stomach sections placed in plastics cassettes, fixed 
with 4% PFA solutions for 24 hours at 4°C and washed 3 times with PBS. Samples were 
paraffin-embedded overnight in Logos One automat, cut into 5μm thick sections and 
stained with hematoxylin and eosin by Anja Kuehl from Charité Core Unit 
Immunopathology for Experimental Models. Hematoxylin and eosin staining was made 
by serial incubation steps. First, 2 minutes with xylene, followed by another 1 minute 
with xylene, 1 minute 100% ethanol, 1 minute 96% ethanol, 1 minute 96% ethanol, 1 
minute 70% ethanol, 1 minute distilled water, 2 minutes with hematoxylin, 1 minute 
with tap water, 1 minute with 70% ethanol, 1 minute with 96% ethanol, 1 minute with 
eosin, 1 minute with 96% ethanol, 1 minute with 100% ethanol, 2 minutes with xylene, 
1 minute with xylene and finally permanently covered with Histokitt. Pictures of the 
section were made with IX50-S8F inverted microscope or Olympus CKX41 and U-
HGLGPS® Fluorescence Illumination Source Microscope and analyzed in ImageJ1.47v 
software. Gland height was measured manually in every third gland of a longitudinal 
section. 
 
2.4.3 SINGLE-MOLECULE RNA IN SITU HYBRIDIZATION 
For ISH, stomach sections were placed in plastic cassettes, fixed with 4% PFA solutions 
for 24 hours at 4°C and washed three times with PBS. Samples were paraffin-embedded 
overnight in Logos One automat and cut into 5μm thick sections by the Charité Core Unit 
Immunopathology for Experimental Models. 
RNA in situ detection was performed with the RNAscope Red Detection Kit (Table 2.8.) 
according to the manufacturer's protocol. Slides were baked for 1 hour at 60°C and 
deparaffinizated with two times 5-minutes xylene incubation followed by two times 5-
minutes 100% alcohol incubation. Hydrogen peroxide was applied for 10 minutes and 
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target retrieval was performed by incubating samples in boiled Target Retrieval 
Reagents for 15 minutes. Slides were washed with distilled water followed by 100% 
alcohol incubation. Hydrophobic barrier was created with Immedge pen around the 
stomach sections. Next day, Protease Plus was applied for 20 minutes at 40°C and 
washed with distilled water. Hybridization with respective probes (Table 2.12.) and 
amplification of the signal was performed in 6 steps with washing in Washing Buffer 
after each incubation. First, slides were incubated for 2 hours at 40°C with probes, then 
30 minutes at 40°C with AMP1, 15 minutes at 40°C with AMP2, 30 minutes at 40°C with 
AMP3, 15 minutes at 40°C with AMP4, 45 minutes at room temperature with AMP5 and 
finally 15 minutes at room temperature with AMP6. Next, sections were incubated in 
Fast Red-A and Fast Red-B reaction mix for 10 minutes in room temperature to detect 
the signal, counterstained in 50% Hematoxylin solution for 2 minutes, washed with 
0,02% Ammonia water, dried for 30 minutes at 60°C, briefly dehydrated with xylene and 
mounted in EcoMount medium. Slides were stored in 
-20°C. 
Pictures of the section were made with IX50-S8F inverted microscope or Olympus CKX41 
and U-HGLGPS® Fluorescence Illumination Source Microscope and analyzed in 
ImageJ1.47v software. Signal was measured automatically per picture or in the indicated 
glands area. 
 
2.5 RNA TECHNIQUES 
2.5.1 RNA ISOLATION 
RNA from organoids and myofibroblasts was isolated with GeneJET RNA Purification Kit 
(Table 2.8.). Organoids from 3 wells were released from matrigel by washing with cold 
PBS and myofibroblasts from 2 wells were collected by trypsinization with TrypLE, 
blocked further with ADF++. Next, cells were centrifuged at 300g for 5 minutes at 4°C, 
washed with PBS and lysed in 600µl Lysis Buffer supplemented with DTT and ethanol. 
RNA isolation was performed as described in manufacturer’s protocol. Total RNA was 
eluted in 40µl RNase-free water followed by concentration and purity measurements 
with the NanoDrop® ND-1000 Spectrophotometer for quantitative reverse transcription 
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polymerase chain reaction (qRT-PCR) analysis or with Agilent 2100 Bioanalyzer and 
NanoDrop 1000 UV-Vis spectrophotometer for microarrays. The samples were stored at 
-80°C until further usage. 
RNA from the whole tissue was isolated with RNeasy Mini Kit (Table 2.8.). Antrum with 
transitional zone was separated from mice, placed in Eppendorf tube and snap frozen in 
liquid nitrogen. Tissue was mashed by using plastic sticks, lysed for 5 minutes in 600µl 
RLT buffer and homogenized with syringe by moving up and down several times until it 
was homogenous. RNA isolation was performed as described in manufacturer’s 
protocol, including on-column DNase digestion and step to dry the membrane. Total 
RNA was eluted in 50µl RNase-free water followed by concentration and purity 
measurements with the NanoDrop® ND-1000 Spectrophotometer. The samples were 
stored at -80°C until qRT-PCR analysis. 
RNA for RNAseq was isolated with RNeasy Plus Micro Kit (Table 2.8.). Myh11+ 
myofibroblasts were sorted directly to 400µl RLT buffer supplemented with DTT and 
kept on ice during sorting process. RNA isolation was performed as described in 
manufacturer’s protocol. Total RNA was eluted in 17µl RNase-free water followed by 
concentration and purity measurements with Agilent 2100 Bioanalyzer. The samples 
were stored at -80°C until RNAseq library preparation. 
 
2.5.2 QUANTITATIVE RT-PCR 
qRT-PCR was performed with Power SYBR Green RNA-to-Ct 1-Step Kit containing master 
mix with nucleic acid dye SYBR Green, Taq DNA-Polymerase and dNTPs as well as reverse 
transcription (RT) enzyme mix with the reverse transcriptase and RNase inhibitors. Apart 
from kit components, primers and DNase/RNase Free Water was added. Primers used 
for qRT-PCR analysis (Table 2.13.) were validated by serial dilutions of RNA-template, 
which was plotted against the threshold cycle (Ct) to create a standard curve. 
The qRT-PCR reaction mixture (Table 2.18.) was prepared without RNA and 15µl/well 
was pipetted into a 96-well plate. 
 
Materials and methods 
48 
 
Table 2.18. qRT-PCR reaction mixture. 
Component per 1 well 
SYBR® green master mix  10 μL  
Primer mix (for+rev primer)  0.5 μL  
H2O  4.3 μL  
RT enzyme mix  0.2 μL  
 
10μl/well of RNA diluted to 5ng/µl was added to the wells with reaction mixture, 
resulting in a total volume of 25μl per well. The plate was covered with a film and put 
into the StepOnePlus Real-Time PCR System in which the two steps of reverse 
transcription and quantitative PCR proceeded using the program suggested by 
manufacturer (Table 2.19.). 
  
Table 2.19. Power SYBR Green RNA-to-Ct 1-Step qRT-PCR program. 
Stage Step Time Temp. 
Holding reverse transcription 30 min  48°C 
Holding inactivation of RT and activation of Taq polymerase 10 min  95°C 
Cycling 
(40 cycles) 
melting of double strands 
primer annealing and elongation 
15 sec  
1 min 
95°C 
60°C 
Melting curve denaturation 
annealing 
denaturation 
15 sec 
15 sec 
15 sec  
95°C 
60°C 
95°C 
 
For each primer pair and RNA-sample the reaction was done in technical duplicate or 
triplicate. The amplification plots obtained from the qRT-PCR were analyzed with the 
Step One Software v2.1. The expression levels were relatively quantified calculating ΔCt 
as well as 2-ΔΔCt with glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as an 
endogenous reference. 
qRT-PCR for Ifnγ was performed by Stefanie Muellerke from the MPIIB Department of 
Molecular Biology with TaqMan Fast Virus 1-Step Master Mix. Briefly, reaction mixture 
was prepared with 5µl/well TaqMan master mix, 1µl/well TaqMan probe and 14μl/well 
of RNA diluted to 5ng/µl and run with the program suggested by manufacturer (Table 
2.20.).  
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Table 2.20. TaqMan Fast Virus 1-Step Master Mix qRT-PCR program for Fast real-time PCR systems. 
Step Cycles Time Temp. 
reverse transcription 1 5 min  50°C 
RT inactivation/initial denaturation 1 20 sec  95°C 
Amplification 40 3 sec  
30 sec 
95°C 
60°C 
 
Relative quantification of gene expression was analyzed by me with the Step One 
Software v2.1 using TaqMan Gapdh probe as an endogenous reference. 
 
2.5.3 MICROARRAY ANALYSIS 
Microarray experiments were performed by Hans Mollenkopf from the MPIIB 
Microarray Core Facility as independent dual-color dye hybridizations using two 
biological replicates. RNA labeling was performed with the dual-color Quick-Amp 
Labeling Kit (Table 2.8.). In brief, mRNA was reverse transcribed and amplified using an 
oligo-dT-T7 promoter primer, and resulting cRNA was labeled with cyanine 3-CTP or 
cyanine 5-CTP. After precipitation, purification, and quantification, 1.25μg of each 
labeled cRNA was fragmented and hybridized to Agilent Technologies whole genome 
mouse 4 × 44k multipack microarrays (Table 2.8.) according to the supplier’s protocol. 
Scanning of microarrays was performed with 5μm resolution using a G2565CA high-
resolution Agilent Technologies laser microarray scanner with extended dynamic range 
(XDR). Microarray image data were analyzed with the Agilent Technologies Image 
Analysis/Feature Extraction software G2567AA v. A.11.5.1.1 using default settings and 
the GE2_1105_Oct12 extraction protocol. The extracted MAGE-ML files were analyzed 
further with the Rosetta Resolver Biosoftware Build 7.2.2 SP1.31. Ratio profiles 
comprising single hybridizations were combined in an error-weighted fashion to create 
ratio experiments. A 1.5-fold change expression cut-off for ratio experiments was 
applied together with anti-correlation of dye-swapped ratio profiles, rendering the 
microarray analysis highly significant (P < 0.01), robust, and reproducible (Churchill 
2002). Microarray data was also analyzed using R (R Core R Core Team 2014) version 
v3.4 and package limma (Ritchie et al. Ritchie et al. 2015) for further analysis. Gene Set 
Enrichment Analysis (GSEA) was performed on genes pre-ranked by gene expression-
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based t-score between PMSS1 infected and uninfected mice and between IFNγ-treated 
and untreated organoids using the fgsea R package (Sergushichev 2016) with 5,000 
permutations. Gene sets from MSigDB v6.2 (Liberzon et al. 2011; Subramanian et al. 
2005) were used. P-values were adjusted for multiple testing by a global false discovery 
rate (FDR) according to the method described by Benjamini and Hochberg (Benjamini 
and Hochberg 1995). 
 
2.5.4 RNA SEQUENCING 
For gene expression analysis of sorted cells, RNAseq libraries were generated together 
with Jeroen Maertzdorf from the MPIIB Department of Immunology. Messenger RNA 
(mRNA) was reverse transcribed and pre-amplified using the SMART-Seq v4 ultra low 
input RNA kit, followed by library generation using a Nextera XT DNA library prep kit 
(Table 2.8.). Sequencing of the libraries was done on an Illumina HiSeq 1500 machine by 
Jeroen Maertzdorf and Hans Mollenkopf and data was analyzed by Hilmar Berger from 
the MPIIB Department of Molecular Biology. 
Briefly, first-strand cDNA synthesis from total RNA was primed by the 3’ SMART-Seq CDS 
Primer II A and template was switched at the 5’ end of the transcript with the SMART-
Seq v4Oligonucleotide. cDNA from the SMART sequences introduced by 3’ SMART-Seq 
CDS Primer II A and the SMART-Seq v4 Oligonucleotide was amplified by PCR Primer II A 
in 12 cycles. PCR-amplified cDNA was purified by immobilization on AMPure XP beads. 
The beads were then washed with 80% ethanol and cDNA was eluted with 17µl Elution 
Buffer. Next, 800pg cDNA was used as input material for library generation and 
tagmented by the Nextera XT transposome, which fragmented the input DNA and 
simultaneously added sequences for sequencing primers to the ends of template DNA. 
Next, adapters were attached to the tagmented DNA fragments for library amplification 
via a limited-cycle PCR program. These sequencing adapters were required for cluster 
formation on the flow-cell and also contained the index 1 (i7) and index 2 (i5) sequences 
for assigning sequence reads to samples during data conversion. Finally, AMPure XP 
beads were used to purify the library DNA and equimolar amounts of sample libraries 
were pooled. The pooled libraries were size-selected (200-1500 bp) on a Pippin Prep 
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platform to remove unbound sequence adapters and create a pool of defined sequence 
lengths. 
Sample loading and cluster generation on the flow-cell was done with the HiSeq PE Rapid 
Cluster Kit v2. Sequencing was run in paired-end (2x50bp) rapid mode with the HiSeq 
Rapid SBS Kit v2 on an Illumina HiSeq 1500 machine. Following bcl-to-fastq conversion 
of the imaging data, sequenced data were further analyzed in our bioinformatics 
pipeline. STAR v2.4 (Dobin et al. 2013) was used to align sequences against mouse 
genome version GRCm38 and htseq-count (Anders, Pyl, and Huber 2015) was used to 
obtain read counts per gene using gene models from Ensembl (www.ensmbl.org) 
GRCm38 v76. Gene expression was analyzed using package DESeq2 (Love, Huber, and 
Anders 2014) and heatmaps were generated in R.
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3 Results 
3.1 MYH11+ MYOFIBROBLASTS RESPOND TO H. PYLORI INFECTION 
3.1.1 MOUSE MODEL 
Epithelial stem cells drive constant regeneration of stomach epithelium and thereby play 
a crucial role in gland organization and turnover (Barker et al. 2007; Matsuo et al. 2017). 
Our previous studies have shown that myofibroblasts surrounding epithelial cells 
express and secrete RSPO3, which appeared to be relevant factor in context of epithelial 
stem cell proliferation (Sigal et al. 2017). Thus, further investigation of stem cell 
microenvironment is important to obtain a more complete view on the impact of niche 
cells for epithelial gland homeostasis. For this purpose, a mouse model enabling 
visualization of the niche myofibroblasts for their further characterization was 
developed. Myh11CreErt2 mice (Herring et al. 2014) with CreErt2 recombinase 
expression under smooth muscle myosin promotor (Myh11) were bred to Rosa26-
mTmG reporter mice (Muzumdar et al. 2007) with membrane activated expression of 
TdTomato (mT) and membrane inactivated, by loxP-flanked genes, expression of green 
fluorescence protein (mG). As a consequence, Myh11CreErt2/Rosa26-mTmG mice were 
generated and in myofibroblasts, which expressed CreErt2 enzyme under the Myh11 
promotor, addition of Tamoxifen enabled excision of loxP-flanked sites, which induced 
conditional expression of GFP specifically in Myh11 lineage (Figure 3.1.a). 
Myh11CreErt2/Rosa26-mTmG mice were treated with 4mg Tamoxifen per 25g mouse 
body weight to induce Cre-driven recombination, sacrificed 7 days later and tissue was 
isolated for further analysis. A protocol enabling confocal microscopy of tissues without 
loss of their fluorescence was developed and consisted of three steps: 1h fixation in 4% 
PFA, immobilization in 4% agarose and vibratome sectioning. Confocal microscopy 
identified GFP+ cells both beneath and between the glands, in direct proximity to 
epithelial cells, whereas the gland epithelium appeared free of GFP. Moreover, staining 
with α-smooth muscle actin (SMA) antibody showed co-localization with GFP 
fluorescence (Figure 3.1.b), indicating that GFP signal in our mice is specific to 
myofibroblasts. Thus, Myh11CreErt2/Rosa26-mTmG mouse model was suitable to 
investigate the regulation of epithelial stem cells by the microenvironment focusing on 
a defined myofibroblasts population. 
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Figure 3.1. Myh11CreErt2/Rosa26-mTmG mice model visualizing myofibroblasts 
Schematic representation of Myh11CreErt2/Rosa26-mTmG mouse (a) and confocal microscopy of 
stomach antrum from mice sacrificed 7 days after Tamoxifen treatment (b). Images show localization of 
GFP signal in Myh11+ myofibroblasts beneath and between the epithelial cells and co-localization of GFP 
signal with αSMA staining. Images are representative of 3 biological replicates. Scale bar 100µm. 
 
Further validation of Myh11+ myofibroblasts was done to confirm that Myh11 gene is 
only expressed in these cells and not in epithelial cells. For this particular experiment, 
Myh11CreErt2/Rosa26-tdTomato mice with TdTomato expression inactivated by loxP-
flanked genes were used. Tamoxifen treatment 7 days before sacrificing excised loxP-
flanked sites and induced TdTomato fluorescence in cells with Myh11 promoter. The 
whole antrum tissue was isolated, dissociated to single cells by incubations with Liberase 
enzymes, stained with EPCAM antibody, which is a specific marker for epithelial cells, 
and taken for FACS sorting. Flow cytometric gating eliminated cell debris and dead cells 
(Figure 3.2.a) and distinguished between dead, PI positive and alive, PI negative cells 
(Figure 3.2.b). Finally, last gate separated Myh11+ myofibroblasts with red fluorescence 
in PE-Texas Red-A channel and EPCAM+ epithelial cells with green fluorescence in APC-
A channel (Figure 3.2.c). FACS plots clearly showed a separation between TdTomato+ 
cells and EPCAM stained cells, and almost none of Myh11+ myofibroblasts were present 
in EPCAM+ gate. This confirmed that TdTomato indeed specifically labelled non-
epithelial cells. 
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Figure 3.2. Flow cytometric analysis of Myh11+ and EPCAM+ cells 
Flow cytometric analysis of Myh11CreErt2/Rosa26-tdTomato antrum tissue showing gates set up for cell 
morphology by SCC-A and FSC-A (a) and living cells stained with PI (b). Last sorting gate distinguished 
Myh11+ myofibroblasts in PE-Texas Red-A channel from EPCAM+ epithelial cells in APC-A channel (c). 
Results are representative of 3 biological replicates. 
 
3.1.2 H. PYLORI INFECTION 
As described before, epithelial stem cells constantly repopulate gastric glands and 
therefore maintain homeostatic turnover. However, environmental changes such as 
infections can promote structural alterations in the glands resulting in pathological 
lesions such as gland hyperplasia, atrophy or metaplasia (Sigal et al. 2015). To get a 
comprehensive view on how the microenvironment changes upon infection and 
whether this drives gland alterations, Myh11CreErt2/Rosa26-mTmG mice were used to 
study how infection with the gastric pathogen H. pylori affects the cells which surround 
the epithelium. Three Myh11CreErt2/Rosa26-mTmG mice were infected for two months 
with WT PMSS1 H. pylori and three mice from the same strain were used as an 
uninfected control. Mice were treated with Tamoxifen, sacrificed 7 days later and antral 
tissue together with transitional zone (zone between antrum and corpus) were 
processed. Focus was put on this part of the stomach because H. pylori gland 
colonization and infection-driven expansion of stem cells was previously described in 
this location (Sigal et al. 2015). Experiment confirmed that infection induces gland 
hyperplasia in antrum and transitional zone, which is consistent with phenotype 
observed by Sigal and others (Sigal et al. 2015). Next, Myh11+ cell lineage that expresses 
GFP in the model were visualized and showed that the increased gland height upon 
infection was accompanied by an expansion of Myh11+ myofibroblasts that surround 
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the gland (Figure 3.3.a). Quantification was done using Volocity software by measuring 
red signal area per picture to determinate gland expansion and green signal area per 
picture to determinate Myh11+ signal in uninfected and infected tissues (Figure 3.3.b). 
Obtained results showed significant increase in TdTomato+ cells due to hyperplasia as 
well as increase of GFP+ Myh11+ myofibroblasts area upon infection with H. pylori. 
 
Figure 3.3. Confocal microscopy of H. pylori infected Myh11CreErt2/Rosa26-mTmG mice 2 months post 
infection (p.i.). 
Representative images of confocal microscopy showing gland hyperplasia with red fluorescence for actin 
or green fluorescence for Myh11+ myofibroblasts expansion (a) and quantification of red or green signal 
area per picture (b) in uninfected and H. pylori infected Myh11CreErt2/Rosa26-mTmG mice 2 months p.i. 
Images are representative of 3 biological replicates. Scale bar 100µm. Data are presented as mean ± 
standard error of the mean (SEM) from 3 biological replicates, analyzed by Student’s t-test. 
 
The fact that myofibroblasts respond to H. pylori infection led to the hypothesis that not 
only the number of these cells changed, but also the gene expression pattern. Therefore, 
another three Myh11CreErt2/Rosa26-mTmG mice were infected for two months with 
WT PMSS1 H. pylori and again three mice from the same strain were used as an 
uninfected control.  Mice were treated with Tamoxifen and sacrificed 7 days later. 
Infection efficiency was confirmed by cultivating the homogenized part of the infected 
stomach on blood agar plates, counting H. pylori colonies and performing CFU 
calculations, which showed 5-7 log10 colonization (Figure 3.4.a). Myofibroblasts were 
isolated from the antrum and transitional zone and taken for FACS sorting to exclude 
debris, dead cells and receive pure Myh11+ myofibroblasts population as described 
above, which was taken further for RNA extraction, library preparation and RNA 
sequencing. Analysis was done by Hilmar Berger from the MPIIB Department of 
Molecular Biology using STAR v2.4 to align sequences against mouse genome (Dobin et 
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al. 2013) and htseq-count to obtain read counts per gene using gene models from 
Ensembl GRCm38 v76 (Anders, Pyl, and Huber 2015). Gene expression was analyzed 
using package DESeq2 (Love, Huber, and Anders 2014) and heatmaps were generated in 
R version3.4 (R Core Team 2014R Core Team 2014). Data analysis from uninfected 
control mice revealed that myofibroblasts express a variety of genes that encode for 
factors involved in regulation of epithelial stem cells through signals such as Wnt, Rspo 
as well as Bmp, and that myofibroblasts express both activators and inhibitors of these 
pathways (Figure 3.4.b). Upon infection with H. pylori, 104 genes were significantly 
upregulated, while 93 genes showed down-regulation compared to uninfected 
myofibroblasts (Figure 3.4.b), indicating that these cells actively respond to H. pylori 
infection. Interestingly, multiple of these genes were from the Bmp signaling pathway. 
Further analysis revealed significant increase in expression of Bmp inhibitors, such as 
Crim1 and Chrdl1 and the same trend for Grem1 and Bambi in myofibroblasts upon 
infection. Moreover, changes in Bmp ligands were observed: significant down-
regulation of Bmp2, Bmp6 and Bmp7, as well as a shift towards reduction for Bmp1, 
Bmp3, Bmp4, Bmp5 and Bmp pathway target genes Id1 and Id2 (Figure 3.4.c). Next, to 
validate these results obtained by RNAseq, qRT-PCR for significantly changed genes with 
the same RNA as used for sequencing was performed. Down-regulation in Bmp1, Bmp2, 
Bmp4, Bmp5, Bmp6 and Bmp7, as well as up-regulation in Chrdl1 expression was 
confirmed (Figure 3.4.d). However, results were significant only for Bmp2, Bmp6, Bmp7 
and Chrdl1, but not for Bmp1, Bmp4 and Bmp5. Thus, H. pylori infection induced overall 
an increased expression of Bmp inhibitors and decreased expression of several Bmp 
ligands in myofibroblasts.  
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Figure 3.4. RNAseq and qRT-PCR validation of Myh11+ myofibroblasts from 2 months H. pylori infected 
mice. 
Number of colony forming units for H.pylori infected Myh11CreErt2/Rosa26-mTmG cells 2 months p.i.(a). 
Heatmap of RNAseq data with genes differentially expressed in uninfected and H.pylori infected Myh11+ 
myofibroblasts 2 months p.i. (b) and highlight of differentially expressed genes involved in Bmp signaling 
(c). qRT-PCR validation of RNAseq data for Bmp-involved genes with the same RNA as used for sequencing 
(d). RNAseq data are from 3 biological replicates per group. qRT-PCR data are presented as mean ±SEM 
from three biological replicates per group, analyzed by Student’s t-test. 
 
3.2 BMP SIGNALING IS SPATIALLY ORGANIZED IN THE STOMACH 
3.2.1 BMP LIGANDS DISTRIBUTION 
Since Bmp signaling showed multiple alterations in infected myofibroblasts, in the next 
step this pathway in the stomach was further investigated. Because both activators and 
inhibitors were expressed in myofibroblasts, the question how they are spatially 
distributed in situ appeared. Bmp ligand distribution in uninfected antrum tissue was 
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examined by performing ISH for Bmp2, Bmp6 and Bmp7, which were significantly 
decreased, and for Bmp4, which showed reduction trend in infected myofibroblasts. 
Bmp2 showed the highest expression and was present in both epithelial and stromal 
cells. Moreover, expression was predominant in the surface of the gland and gradually 
decreased towards the base. The base itself was free of Bmp2 (Figure 3.5.a). Other Bmp 
ligands were expressed at lower levels, Bmp4 expression was restricted to the stroma 
and equally distributed along the gland axis (Figure 3.5.b), whereas expression of Bmp6 
and Bmp7 was much lower (Figure 3.5.c) and therefore it was not further examined. To 
quantify the distribution along the gland axis, tissue was divided into the surface and 
bottom part and signal for Bmp2 and Bmp4 was quantified using ImageJ1.47v software. 
In the top of the gland, average Bmp2 expression was 15 times higher than in the bottom 
and there was no Bmp2 signal within the stem cell compartment (Figure 3.5.d). 
Quantification of Bmp4 ligand confirmed our observations showing no significant 
changes in the expression between the top and the bottom of the gland (Figure 3.5.e). 
In summary, Bmp2 expression was dominant in the surface of the gland, whereas Bmp4 
is equally distributed along gland. 
 
Figure 3.5. ISH for Bmp ligands in antrum tissue. 
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Light microscope pictures of ISH for Bmp2 (a), Bmp4 (b), Bmp6 and Bmp7 (c). High magnification and 
quantification divided for top and bottom of the gland for Bmp2 (d) showing Bmp2 dominant expression 
in the surface of the gland and for Bmp4 (e) showing equal distribution along gland height. Images are 
representative of at least 3 biological replicates. Scale bar 100µm. Data are presented as mean ±SEM from 
3 biological replicates, analyzed by Student’s t-test. 
 
3.2.2 BMP INHIBITORS DISTRIBUTION 
RNAseq of infected myofibroblasts showed not only alterations in Bmp ligand expression 
but also up-regulation of Bmp inhibitors. Therefore, Bmp inhibitors distribution in 
uninfected antrum tissue was also examined by performing ISH. Inhibitors changed in 
RNAseq like Chrdl1 and Grem1 were chosen for the assay as well as Noggin, which is 
described as a main Bmp inhibitor in the intestine (He et al. 2004) and Grem2 by its 
similarity to Grem1. ISH showed high expression of Grem1, Grem2 and Chrdl1 in the 
stroma located beneath the glands (Figure 3.6.a), so in the close proximity to the 
epithelial stem cell compartment. Surprisingly, Noggin, which is commonly present in 
the intestine was not detected in the mouse stomach (Figure 3.6.b). Next, these 
observations were quantified using ImageJ1.47v software. However, since Bmp 
inhibitors expression was strongly limited to the base, this time the tissue was divided 
into the base and rest of the gland to quantify the distribution along the gland axis, as 
indicated on Figure 3.6.a. Quantification analysis of ISH showed that Grem1 and Grem2 
and especially Chrdl1 expression was limited to the base (Figure 3.6.c). Together, these 
data depict the highly organized distribution of Bmp signaling molecules in gastric 
glands, with strong expression of Bmp2 in the surface region and absence of Bmp2 as 
well as expression of Bmp inhibitors in the base. 
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Figure 3.6.  ISH for Bmp inhibitors in antrum tissue. 
Light microscope pictures and high magnifications of ISH for Grem1, Grem2, Chrdl1 (a) and Noggin (b). 
ISH quantification divided for base and rest of the gland for Grem1, Grem2 and Chrdl1 (c) showing 
inhibitors distribution limited to the base. Images are representative of at least 3 biological replicates. 
Scale bar 100µm. Data are presented as mean ±SEM from 3 biological replicates, analyzed by Student’s t-
test. 
3.3 H. PYLORI INFECTION ALTERS BMP SIGNALING 
3.3.1 BMP LIGANDS UPON INFECTION 
To further characterize Bmp signaling and its changes upon H. pylori infection, Bmp 
ligand distribution was investigated in infected samples by ISH. Three C57BL/6 mice 
were infected for 2 months with WT PMSS1 H. pylori and three uninfected C57BL/6 mice 
served as controls. Stomach was separated, processed further, ISH for Bmp2 and Bmp4 
was performed and investigated in the antral part of the stomach. ISH revealed strong 
decrease in Bmp2 expression in the gland surface including both stroma and epithelial 
cells, which confirmed the results of the RNAseq. Despite the increase of gland height, 
Bmp4 expression remained at a similar level (Figure 3.7.a) in infected samples compared 
to uninfected. To confirm those observations, signal area was quantified per picture 
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using ImageJ1.47v software, which revealed almost seven times lower expression of 
Bmp2 in the infected samples compared to uninfected and no significant changes for 
Bmp4 expression were detected (Figure 3.7.b). Thus, H. pylori infection down-regulated 
Bmp2 in the top of the gland and did not affect Bmp4 distribution. 
 
Figure 3.7. ISH for Bmp ligands in 2 months H. pylori infected antrum. 
Light microscope pictures of ISH for Bmp2 and Bmp4 in antrum tissue from 2 months H. pylori infected 
C57BL/6 mice (a). ISH quantification of signal area per picture for Bmp2 showing Bmp2 decrease upon 
infection and for Bmp4 showing no significant changes (b). Images are representative of at least 3 
biological replicates. Scale bar 100µm. Data are presented as mean ±SEM from 3 biological replicates, 
analyzed by Student’s t-test. 
3.3.2 BMP INHIBITORS UPON INFECTION 
In the next step, changes in Bmp inhibitors distribution upon H. pylori infection were 
investigated by ISH with the same 2 months infected and uninfected tissues, which were 
used for Bmp ligands examination. Microscope pictures visualized an increased 
expression of Chrdl1 as well as Grem2 in infected samples, which was quantified and 
confirmed the observation. Surprisingly, Grem1 did not show a significant increase upon 
infection when quantified in the antrum (Figure 3.8.a-b). However, focus specifically on 
the transitional zone between antrum and corpus showed significant increase of Grem1 
and Grem2 upon infection in this area (Figure 3.8.c-d). This area is highly colonized by 
gland-associated H. pylori (Van Zanten, Dixon, and Lee 1999) and gland hyperplasia as 
well as antral metaplasia is often observed in this part of the stomach. Taken together, 
H. pylori infection affects the spatial distribution of Bmp signaling molecules, it down-
regulates Bmp2 in the top of the gland and up-regulates Bmp inhibitors located in the 
gland base. 
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Figure 3.8. ISH for Bmp inhibitors in 2 months H. pylori infected antrum and transitional zone. 
Light microscope images of ISH for Grem1, Grem2 and Chrdl1 in antrum tissue from 2-months H. pylori 
infected C57BL/6 mice and uninfected controls (a) and ISH quantification of signal area per picture for 
Bmp inhibitors showing significant increase for Grem2 and Chrdl1 upon infection (b). Light microscopy 
pictures and quantification of ISH for Grem1 (c) and Grem2 (d) 2 months H. pylori infected transitional 
zone showing significant increase. Images are representative of at least 3 biological replicates. Scale bar 
100µm. For quantification 10 images per mouse were analyzed and the average value per image was 
calculated. Data are presented as mean ±SEM from 3 biological replicates, analyzed by Student’s t-test. 
 
3.4 BMP PROMOTES SURFACE AND INHIBITS BASAL PHENOTYPE 
3.4.1 DIFFERENTIATION MARKERS 
While the data presented in the previous sections described Bmp distribution and 
changes upon H. pylori infection, the function of BMP signaling in the stomach remained 
not clear. The cellular distribution with gastric antral glands appears highly 
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compartmentalized so the question whether this could be driven by the discovered 
spatial restriction of Bmp signaling appeared. Antrum gland contains various cells such 
as subpopulations of Lgr5+ cells in the base that are either proliferative stem cells or 
secretory cells expressing markers such as Muc6+ and Gif+ (Sigal et al. 2019), the highly 
proliferative Axin2+ stem cells in the lower isthmus and Muc5ac+ mucous pit cells in the 
surface region (Figure 3.9.a). Examining the influence of BMP signaling on cellular 
differentiation in the stomach required a cell culture model that represented all gastric 
cell types. Therefore, three-dimensional (3D) organoids model, which enables in vitro 
differentiation of epithelial cells by selection of medium factors was used. Once 
organoids were established in full medium, they were exposed to recombinant BMP2 or 
BMP4 and a rapid growth inhibition compared to controls kept without BMPs was 
observed (Figure 3.9.b). As described above, the stem cell compartment in the antrum 
is exposed to Bmp inhibitors that are robustly expressed in the stroma underlying the 
gland base. Therefore, the function of these factors was also investigated and indeed, 
addition of BMP inhibitors such as CHRDL1, GREM1 and GREM2 to the culture with BMP 
ligands was sufficient to block the effect of BMPs resulting in organoids that were 
phenotypically similar to the ones cultured in normal medium (Figure 3.9.b). Next, qRT-
PCR for differentiated genes in organoids treated with BMP2 and BMP4 was performed 
to examine cell differentiation state. Strong increase in expression of BMP target gene 
Id1 upon treatment with BMP was observed, confirming that addition of recombinant 
BMP indeed efficiently induced the BMP pathway. Next, genes, which are known to be 
specific for cellular populations in the gland were selected. A strong down-regulation of 
the stem cell marker Lgr5 as well as secretory gland base cell marker Muc6 upon BMP 
treatment was observed, whereas the surface pit cell marker Muc5ac was strongly and 
significantly up-regulated. Expression of isthmus stem cell gene Axin2 and 
enteroendocrine cell markers such as Gast and Chga remained unchanged. BMP2 and 
BMP4 had a similar effect on the expression of the selected genes, although changes in 
expression were slightly stronger for BMP2 (Figure 3.9.c). To ask how BMP inhibitors 
affect differentiation, Qrt-PCR for the same markers with RNA from organoids treated 
with BMP4 together with Bmp inhibitors was run and confirmed that each of them was 
sufficient to block the BMP-driven differentiation (Figure 3.9.d). Thus, the conducted 
Results 
64 
 
experiments demonstrated that BMP promotes differentiation into gland surface cells 
and inhibits gland base cell identity, which can be maintained by BMP inhibitors. 
 
Figure 3.9. BMP ligands and inhibitors treatment in 3D organoids model. 
Schematic representation of different gastric antrum cells and their markers (a). Images of organoids from 
antral epithelium grown in full organoid medium and either untreated and treated with BMP2 and BMP4 
separately or BMP4 together with BMP inhibitors: CHRDL1, GREM1 and GREM2 (b) showing inhibited 
growth of organoids upon treatment with BMP ligands and restored phenotype by addition of BMP 
inhibitors. qRT-PCR for BMP target gene and markers characteristic for specific gland cells from organoids 
untreated and treated with BMP2 and BMP4 (c) and organoids treated with BMP4 separately or together 
with BMP inhibitors: CHRDL1, GREM1 and GREM2 (d) showing induction of differentiation into gland 
surface cells and inhibition of gland base markers, induced by BMP and restored by inhibitors. Images are 
representative of at least 3 biological replicates. Scale bar 250µm. Data are presented as mean ±SEM from 
3 biological replicates, analyzed by Student’s t-test. 
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Since BMP signaling was altered upon H. pylori infection and effects of BMP2 on cellular 
differentiation in organoids were identified, it was further investigated whether similar 
differentiation changes occur upon infection in vivo. Thus, tissue from uninfected and 2-
months H. pylori-infected mice was stained with markers that showed the highest level 
of alteration upon BMP treatment of organoids. Indeed, MUC5AC signal in the surface 
decreased upon infection (Figure 3.10.a) and GSII+ gland base secretory cells 
(reminiscent of Muc6+ cells) increased upon infection (Figure 3.10.b). These 
observations are consistent with our previous findings showing an expansion of Lgr5+ 
stem cells as well as gland base secretory cells upon infection (Sigal et al. 2017; Sigal et 
al. 2019). In summary, changes upon infection resemble changes observed upon BMP 
inhibition, indicating that loss of BMP signaling could drive these processes in vivo.  
 
Figure 3.10. Confocal microscopy of stomachs stained for differentiation markers in 2 months H. pylori-
infected mice. 
Confocal microscopy images of uninfected and 2 months H. pylori infected mice labeled with MUC5AC (a) 
and GSII (b) showing reduction of gland surface markers and induction of gland base cells upon infection. 
Images are representative of at least 3 biological replicates. Scale bar 100µm. Data are presented as mean 
±SEM from 3 biological replicates, analyzed by Student’s t-test. 
 
 
3.4.2 ANTIMICROBIAL GENES 
Our previous studies have identified that a subpopulation of basal Lgr5+ cells are able 
to secrete antimicrobial factors such as Intelectin 1 (Itln1) and Regenerating family 
member 3 beta/gama (Reg3b/g) to counterbalance H. pylori infection (Sigal et al. 2019). 
Since BMP inhibition appeared to shape the gland base compartment, it was 
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hypothesized that BMP has an impact on the expression of these antimicrobial genes. 
Itln1, Reg3b and Reg3g expression was examined in organoids cultured with exogenous 
BMP2 and BMP4. qRT-PCR showed strong decrease for all antimicrobial genes in 
samples treated with both BMP2 and BMP4. However, down-regulation was stronger in 
organoids cultured with BMP2 (Figure 3.11.a). Next, influence of BMP inhibitors on 
antimicrobial genes was examined and expression of Itln1, Reg3b and Reg3g was found 
to be restored with all the inhibitors, compared to expression in samples treated with 
BMP4 only (Figure 3.11.b). Together, these data demonstrate that BMP signaling is a 
critical determinant not only in gastric epithelial differentiation but may play also crucial 
role in the antimicrobial response to H. pylori infection. 
 
Figure 3.11. qRT-PCR results of antimicrobial respond to BMP treatment in 3D organoids model. 
qRT-PCR for antimicrobial genes from organoids untreated and treated with BMP2 and BMP4 (a) and 
organoids treated with BMP4 separately or together with BMP inhibitors: CHRDL1, GREM1 and GREM2 
(b) showing reduction in antimicrobial genes expression upon BMP ligands treatment and restored 
expression with BMP inhibitors. Data are presented as mean ±SEM from 3 biological replicates, analyzed 
by Student’s t-test. 
 
3.5 BMP2 DRIVES FULL DIFFERENTIATION OF SURFACE MUCOUS CELLS 
3.5.1 COMPARISON OF THE ROLES OF WNT AND BMP IN ORGANOIDS MODEL 
Gastric gland homeostasis, including epithelial differentiation and proliferation, is 
shaped by different pathways and factors (de Lau et al. 2011; Demitrack et al. 2015). 
Our previous work has shown that myofibroblasts below the epithelial stem cells 
expressed high levels of WNT/β-catenin signaling modulator Rspo3 (Sigal et al. 2017). It 
has been described that the location and amount of this factor correlates with the 
concentration of WNT target genes in the gland base and lower isthmus epithelium. 
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Experiments with organoid culture has confirmed that RSPO is important for epithelial 
stem cells. Removal of WNT or RSPO from the culture medium increased differentiation 
and led to enrichment of surface markers, indicating that once cells exit the gland base 
compartment they start to differentiate into surface cells. Therefore, roles of Bmp and 
Wnt/RSPO were compared. Effects of RSPO-depletion and BMP activation were 
juxtaposed by culturing organoids epithelium in medium without RSPO only, without 
RSPO and with 50% reduced WNT3A and with addition of recombinant BMP2. As 
expected, both reduction of WNT signaling and activation of BMP pathways decreased 
in organoids growth. Quantification of organoids diameters showed that all the 
conditions induced similar reduction in organoids size (Figure 3.12.a), indicating that 
inhibition of WNT and activation of BMP have comparable influence on epithelial 
proliferation. However, investigating gene expression levels revealed significant 
differences in the effects of the studied pathways. Depletion of RSPO from culture 
medium was not sufficient to induce increase of Id1, together with reduced WNT it 
slightly up-regulated this BMP target gene, whereas BMP2 treatment led to 10-fold 
change in expression (Figure 3.12.b). Expression of gland base cell markers showed that 
both, reduction of WNT signaling and addition of BMP2 induced significant down-
regulation of Lgr5, Muc6 and Gif genes, but the effect of BMP2 was much stronger 
leading to an almost complete loss of all these markers. The same pattern was observed 
when examining expression of Muc5ac surface marker. As expected, removal of 
WNT/RSPO induced Muc5ac expression, but BMP2 treatment induced it three times 
stronger (Figure 3.12.c). 
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Figure 3.12. Organoids size and qRT-PCR analysis of cells cultured with reduced WNT/RSPO or addition 
of BMP2. 
Organoids pictures and size quantification of cells cultured with reduced WNT/RSPO and addition of BMP2 
(a) showing similar reduction of organoids growth in indicated conditions. qRT-PCR analysis of BMP target 
gene (b), basal and surface markers (c) showing reduction in basal genes and induction in Muc5ac 
expression with reduced WNT/RSPO and addition of BMP2, but much stronger effect for BMP2 treatment. 
Images are representative of 3 biological replicates. Scale bar 250µm. Data are presented as mean ±SEM 
from 3 biological replicates, analyzed by Student’s t-test. 
 
Since BMP had much stronger influence on epithelial cell plasticity than the reduction 
of WNT signaling, question of its influence on stemness appeared. To compare the effect 
of both conditions on stemness, organoids were cultured with or without exogenous 
BMP2 in normal medium, medium without RSPO only or without RSPO together with 
50% reduced WNT. Next, organoid forming efficiency from passaged organoid cells 
seeded in the same cell number for all the conditions and cultured further in normal 
gastric organoid medium was measured. After the passage, cells kept in different 
medium conditions without BMP2, even upon removal of WNT/RSPO were able to 
create organoids when put back in normal medium. However, cells treated with BMP2, 
irrespectively of WNT/RSPO signaling, did not create any organoids (Figure 3.13.a-b), 
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indicating that exposure to BMP2 protein completely blocked stemness. Taken together, 
these data show that BMP signaling inhibits basal markers, induces differentiation into 
surface cells, leads to loss of stemness and promotes differentiation to surface mucous 
cells much stronger than reduction of WNT signaling. 
 
Figure 3.13. Pictures and numbers of passaged organoids cultured with reduced WNT/RSPO or addition 
of BMP2. 
Pictures (a) and quantification (b) of organoids cultured with reduced WNT/RSPO or addition of BMP2, 
passaged and cultured further in normal organoids medium showing loss of stemness properties after 
treatment with BMP2, but not after the culture with reduced WNT/RSPO. Images are representative of 3 
biological replicates. Scale bar 250µm. Data are presented as mean ±SEM from 3 biological replicates, 
analyzed by Student’s t-test. 
 
3.5.2 BMP2 AUTOCRINE LOOP 
As showed above BMP ligands appear to be critical drivers of epithelial differentiation 
and question how Bmp2 expression, that is found in the surface and not base of the 
gland, is regulated appeared. To identify the condition that influences Bmp2 expression, 
qRT-PCR for Bmp2 expression was performed with organoids cultured with different 
conditions elaborated above such as reduced WNT/RSPO or addition of BMP2 and BMP4 
in the medium. While WNT/RSPO depletion did not influence on Bmp2 expression, 
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strong and significant increase was observed upon BMP2 and BMP4 treatment (Figure 
3.14.a). This led us hypothesize that Bmp2 induces itself in auto-paracrine loop, where 
once the cell encounters Bmp2, it starts to express it and turns on an autocrine loop, 
which further stabilizes and enhances the effect of Bmp2. To address this, organoids 
experiment with different BMP2 concentrations was performed with the help of 
Manqiang Lin from the MPIIB Department of Molecular Biology. Organoids were 
cultured with BMP2 concentrations from 0 to 50 ng/ml and their size, number and genes 
expression were examined. Indeed, significant alterations in differentiation genes 
expression identified previously by us as effect of BMP2 treatment were observed with 
the BMP2 concentration sufficient to induce Bmp2 expression. Once the expression of 
Bmp2 was induced, expression of differentiation markers changed significantly – 
expression of Muc5ac was strongly induced, whereas expression of Muc6 and Lgr5 
almost completely lost (Figure 3.14.b). Additionally, organoids after the treatment with 
different BMP2 concentrations were passaged and cultured further with normal 
medium to investigate the organoid forming capacity. Interestingly, the number of 
formed organoids after passage corresponded with previous observations – BMP2 
concentration that was sufficient to induce endogenous Bmp2 expression was the 
breaking point in which organoids number dropped significantly to almost zero (Figure 
3.14.b). In contrast, organoids cultured with doses of BMP2 that was below the 
threshold to induce Bmp2 expression were still able to re-grow and developed into 
organoids after passage. (Figure 3.14.c). Taken together, these experiments indicated 
that Bmp2 expression in epithelial cells is regulated by BMP2 auto/paracrine loop, 
which, when switched on, leads to differentiated phenotype and loss of stemness 
properties. 
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Figure 3.14. qRT-PCR, number and morphology analysis of organoids cultured with different BMP2 
concentrations. 
qRT-PCR for Bmp2 in organoids cultured with reduced WNT/RSPO or addition of BMP2 and BMP4 (a) 
showing induced Bmp2 expression upon BMP2 and BMP4 treatment. Expression of differentiated genes, 
organoids number (b) and organoids phenotype (c) in culture treated with different BMP2 concentration 
indicating that effect of BMP2 on differentiated genes and impaired colony forming efficiency corresponds 
with induction of Bmp2 expression in epithelial cells. Images are representative of 3 biological replicates. 
Scale bar 250µm. Data are presented as mean ±SEM from 3 biological replicates, analyzed by Student’s t-
test. 
 
3.5.3 BMP AND RSPO REGULATION IN MYOFIBROBLASTS 
As mentioned above, our previous studies showed that Rspo3, which is an important 
modulator of WNT signaling in epithelial stem cells, is expressed exclusively in 
myofibroblasts beneath the gastric gland (Sigal et al. 2017). In contrast, stroma 
surrounding surface of the gland showed no signal for this factor, whereas the current 
study revealed that it is enriched in Bmp2 expression (Figure 3.5.a, d). Mutually exclusive 
sites of expression led us hypothesize that these signaling pathways negatively affect 
each other. To investigate this relationship, primary myofibroblasts from 
Myh11CreErt2/Rosa26-tdTomato mice were isolated and a culture of these cells was 
established. Confocal imaging of cultured cells, which were extracted from the tissue 
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showed that after two passages they mainly consist of Myh11+ myofibroblasts. 
Moreover, staining with vimentin as marker of mesenchymal cells was performed and 
demonstrated strong enrichment of the signal, which was mostly co-located with Myh11 
fluorescence confirming mesenchymal character of the cells (Figure 3.15.). 
 
Figure 3.15. Confocal microscopy of myofibroblasts culture from Myh11CreErt2/Rosa26-tdTomato mice. 
Representative images of confocal microscopy with Myh11+ myofibroblasts stained with Vimentin 
antibody, confirming mesenchymal character of the cells. Images are representative of 3 biological 
replicates.  
 
Next, myofibroblasts were treated with exogenous recombinant RSPO3 or BMP2. While 
addition of RSPO3 did not induce any changes in Bmp2 expression (data not shown), 
myofibroblasts responded to BMP treatment and showed a significant decrease in 
Rspo3 expression. Additionally, BMP inhibition using rNoggin was further examined. 
Expression of BMP target gene Id1 was induced by addition of BMP2 and reduced with 
Noggin, indicating that myofibroblasts actively respond to the treatment. Moreover, 
expression of Rspo3 in myofibroblasts was inversely correlated with BMP activation. 
With addition of rNoggin, when Id1 was down-regulated, expression of Rspo3 increased 
almost 2-fold, whereas during BMP2 treatment and up-regulation of Id1, expression of 
Rspo3 decreased almost by half (Figure 3.16.a). Investigation of different BMP2 
concentrations showed that the induction of Bmp2 target gene Id1 was increasing with 
higher concentration and that loss of Rspo3 expression showed the same concentration 
dependency (Figure 3.16.b). To ask whether BMP2 reduced Rspo3 expression or 
whether it selectively affected the expansion of subpopulations of Rspo3 positive versus 
Rspo3 negative cells, EdU proliferation assay was performed and no significant 
difference in proliferation upon BMP2 treatment was observed (Figure 3.16.c). Thus, the 
data indicated that Rspo3 expression in myofibroblasts is inhibited by BMP signaling, 
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which may explain the spatial separation of Bmp2+ cells versus Rspo3-positive cells. 
Moreover, it may be an explanation for increased Rspo3 expression upon infection with 
H. pylori. 
 
Figure 3.16. qRT-PCR and EdU assay of myofibroblasts culture treated with BMP2 and Noggin. 
qRT-PCRs of myofibroblasts cultured with BMP2, Noggin (a) and with different BMP2 concentrations (b) 
showing inverse correlation between induction of BMP pathway and Rspo3 expression. Edu proliferation 
assay with myofibroblasts treated with BMP2 (c) showing no differences in proliferation upon the 
treatment. Images are representative of 3 biological replicates. Data are presented as mean ±SEM from 3 
biological replicates, analyzed by Student’s t-test. 
 
3.6 H. PYLORI REGULATES BMP SIGNALING THROUGH IFNγ 
3.6.1 ROLE OF H. PYLORI T4SS IN BMP2 REGULATION 
Finally, a connection between infection with H. pylori and reduction of BMP signaling 
was further explored. To address this, tissue responses to H. pylori infection were 
revisited. H. pylori T4SS represents a well-studied virulence machinery of H. pylori, 
required for injection of CagA and other virulence factors such as ADP heptose into host 
cells and is required for the full expansion of Lgr5+ cell upon infection (Sigal et al. 2015). 
To examine whether functional T4SS is required for Bmp2 inhibition upon infection, 
isogenic mutant lacking the CagE gene, making the T4SS dysfunctional was used (Arnold, 
Lee, et al. 2011). Stomachs from mice infected with ΔCagE PMSS1, compared to 
stomachs infected with the wild-type PMSS1 strain for two months, showed less 
hyperplasia (Figure 3.17.a) and less Ki67+ proliferating cells (Figure 3.17.b). Next, Bmp2 
changes in mice infected with both strains were examined by ISH. WT PMSS1 infected 
mice had an almost complete loss of Bmp2 expression. However, mice infected with 
ΔCagE PMSS1 still expressed Bmp2 on high level, indicating that Bmp2 loss depends on 
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a functional T4SS (Figure 3.17.c). To identify the specific factor or signal responsible for 
Bmp2 down-regulation, microarray with uninfected and 2 months H. pylori infected WT 
PMSS1 mice was performed and GSEA showed the highest level of enrichment for IFNγ 
response genes (Figure 3.17.d). Expression of Ifnγ was then examined in mice infected 
with WT and ΔCagE PMSS1. qRT-PCR data revealed significantly higher expression of Ifnγ 
in WT infected animals indicating that the strong induction of Ifnγ expression upon 
infection requires the T4SS (Figure 3.17.e). 
 
 
Figure 3.17. Tissue analysis, microarray and qRT-PCR of mice infected with WT and ΔCagE mutant. 
H&E staining (a), confocal images of Ki67 staining (b) and ISH for Bmp2 (c) of stomachs infected with WT 
and ΔCagE mutant showing less hyperplasia, less proliferation and high levels of Bmp2 in ΔCagE mutant 
compared to WT. Microarray GSEA in WT infected stomachs compared to uninfected (d) showing high 
enrichment in IFNγ response genes. qRT-PCR for Ifnγ showing significantly higher expression in WT 
infected animals. Images are representative of at least 3 biological replicates. Scale bar 100µm. Data are 
presented as mean ±SEM from 3 biological replicates, analyzed by Student’s t-test. 
 
3.6.2 IFNγ INFLUENCE ON ORGANOIDS PLASTICITY 
As showed above, both induction of Ifnγ signaling and reduction of Bmp2 expression 
were induced in T4SS dependent manner. Similar phenotype and connection to 
infection made us wonder whether IFNγ will affect organoids growth, stemness and 
Bmp2 expression. To address this, gastric organoids were treated with recombinant IFNγ 
and changes in gene expression level were investigated. To confirm that cells respond 
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to IFNγ, Ifnγ target gene Irf1 was selected and confirmed a strong increase in expression 
upon treatment. Next, examination whether IFNγ is affecting BMP signaling was 
performed by investigating changes in Id1 expression. Interestingly, Id1 expression was 
significantly down-regulated, whereas the expression of Lgr5 was significantly 
increased. Strikingly, expression of Bmp2 was also down-regulated in IFNγ treated 
organoids, indicating that IFNγ could block the induction of endogenous Bmp2 signaling 
cascade (Figure 3.18.a). To determine whether these effects depend on the IFN-γ 
receptor, experiments were repeated with organoids isolated from IFNγ receptor KO 
mice (Huang et al. 1993). This time, there was no increase in Irf1 expression as well as 
no changes in Bmp2, Id1 and Lgr5 expression, indicating that IFNγ-driven effects are via 
its interaction with the IFNγ receptor (Figure 3.18.b). Moreover, culture with different 
concentrations of IFNy showed that already low concentration of 3ng/ml of IFNγ is 
sufficient to induce changes of indicated genes. Expression stays on the similar level 
even with 500ng/ml, indicating that IFNγ driven changes in Irf1, Bmp2, Id1 and Lgr5 
expression are induced at low concentration and don’t increase further (Figure 3.18.c).   
To examine in detail the response of organoids to IFNγ, microarray from organoids 
culture with addition of IFNγ was performed. Interestingly, GSEA showed a significant 
enrichment of genes identified as down-regulated BMP2 targets by Lee et al in the 
mouse uterus upon KO of Bmp2 (Lee et al. 2007) (Figure 3.18.d), whereas genes 
described as up-regulated BMP2 targets in the same system were significantly reduced 
upon IFNγ treatment (Figure 3.18.e), which demonstrates that IFNγ suppressed the 
BMP2 signaling. Of note, there was no significant enrichment for gene sets associated 
with Wnt signaling such as “Beta catenin targets”. Therefore, the induction of Lgr5 
expression upon IFNγ was more likely to be induced by loss of BMP2 signaling than by 
induction of WNT pathway (Figure 3.18.f).  
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Figure 3.18. qRT-PCR and microarray analysis of organoids treated with IFNγ. 
qRT-PCR for WT (a) and IFNγRKO (b) organoids cultured with IFNγ showing Bmp2 inhibition upon IFNγ 
treatment. qRT-PCR with different IFNγ concentrations (c) showing that gene expressions levels do not 
changed with higher IFNγ concentration. Microarray analysis of organoids treated with IFNγ showing 
enrichment for down-regulated BMP2 targets (d), reduction for up-regulated BMP2 targets (e) and no 
significant changes for Beta catenin targets (f). For qRT-PCR results data are presented as mean ±SEM 
from 3 biological replicates, analyzed by Student’s t-test. For microarrays analysis 2 biological replicates 
were used. 
 
Since IFNγ inhibits anti-proliferative Bmp2 and increases Lgr5 expression, addition of 
IFNγ to the culture should induce organoids growth and development. However, 
treatment with this recombinant protein led to a rather decreased organoid growth and 
less outgrowth of organoids after passage (Figure 3.19.a).  To understand this further, 
Lgr5+ cell lineage tracing was performed in organoids: organoids from 
Lgr5CreEr/Rosa26tdTomato mice were cultured with IFNγ as previously, then treated 
with 4OH-tamoxifen for 24h to induce lineage tracing, passaged, seeded as single cells 
and proportion of organoids created from tdTomato positive to tdTomato negative 
organoids was calculated. Interestingly, the proportion of Lgr5+ to Lgr5- organoids was 
higher in cells treated with IFNγ before the passage compared to cells untreated with 
IFNγ (Figure 3.19.b). Thus, this experiment showed that IFNγ-reduced stemness in Lgr5+ 
cells, whereas Lgr5-negative cells had a higher likelihood to grow into organoids, overall 
being an indicator for an altered stem cell hierarchy. 
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Since IFNγ inhibited Bmp2 expression, question whether the terminal differentiation 
induced by Bmp2 signaling will be lost by co-treatment of cells with IFNγ appeared. 
Organoids were treated with BMP2 or IFNγ, but also with BMP2 and IFNγ together and 
qRT-PCR was performed. Addition of IFNγ together with BMP2 blocked the 
overexpression of Muc5ac and Bmp2 induced by BMP2 only, but there were no changes 
in the decreased expression of Lgr5 (Figure 3.19.c). Next, colony forming efficiency was 
examined by passaging treated organoids and culturing them further in normal medium. 
As previously, cells treated with BMP2 created only 5 organoids per well and mostly 
stayed on single cell level. However, cells cultured with BMP2 and IFNγ could be passed 
and developed organoids, indicating that IFNγ blocked BMP2-induced terminal 
differentiation and enhanced stem cell plasticity in differentiating cells (Figure 3.19.d).  
 
Figure 3.19. Organoids culture and qRT-PCR of cells treated with BMP2 and IFNγ. 
Organoids number quantification (a) and Lgr5 lineage tracing induced by Tamoxifen 24h before the 
passage (b) of organoids treated with IFNγ showing reduced stemness capacity and reduced Lgr5+ driven 
organoids formation. qRT-PCR for Bmp2, Muc5ac and Lgr5 treated with BMP2, IFNγ or with both factors 
together (c) showing that IFNγ blocks BMP2-driven overexpression of Muc5ac and Bmp2, but no changes 
for Lgr5. Colony forming efficiency for cells treated with BMP2 and BMP2 together with IFNγ (d) showing 
increased stemness capacity after IFNγ addition. Images are representative of 3 biological replicates. Scale 
bar 250µm. Data are presented as mean ±SEM from 3 biological replicates, analyzed by Student’s t-test.
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4 Discussion 
H. pylori is one of the most widespread bacteria and colonizes more than 50% of the 
world population (Pounder and Ng 1995). Thanks to Barry Marshall and Robin Warren it 
has been identified as the causing agent of chronic gastritis as well as other gastric 
pathologies (Marshall et al. 1985). Further examination of H. pylori influence revealed 
its contribution to gastric precancerous processes. Accordingly, it has been classified as 
a class I carcinogen in 1994 by the WHO (IARC 1994). The important role of H. pylori in 
cancer development evoked interest in understanding the mechanisms of disease 
development. Many studies focusing on bacterial factors required for colonization and 
adaptation to gastric environment were performed. Moreover, epidemiological and 
mechanistic studies enabled defining bacterial virulence factors, especially VacA, 
bacterial adhesins and cagPAI (Palframan, Kwok, and Gabriel 2012; Sheu et al. 2012; 
Khatoon et al. 2017). On the other hand, gastric alterations induced by H. pylori that 
define pathological states ranging from gastritis, through atrophy, intestinal metaplasia, 
dysplasia to gastric cancer were characterized in patients (Correa et al. 1975; Correa and 
Piazuelo 2012).  
However, little is known about the mechanistic principles of epithelial cell responses to 
infection and the development of tissue pathology. In this study, I explored the 
mechanistic basis of gastric epithelial regeneration, plasticity and differentiation in both 
uninfected healthy state as well as upon infection with H. pylori. In this context, my study 
aimed at characterizing the molecular linkages between the infection, inflammation and 
epithelial pathology.  
I identified myofibroblasts surrounding the epithelial gland cells as cells that generate a 
BMP signaling gradient along the gland axis from BMP inhibition in the base to high BMP 
signaling in the surface. This gradient guides epithelial cell differentiation from the basal 
stem cells towards secretory mucous cells at the gland surface. Once BMP signaling is 
activated in epithelial cells, it induces an auto-/paracrine feed-forward BMP2 loop in 
epithelial cells that stabilizes the BMP signaling pathway and therefore limits plasticity 
leading to terminal differentiation. Moreover, my results showed strong induction of 
IFNγ signaling in the stomach upon infection and I identified its inhibitory effect on BMP 
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signaling. This leads to a termination of paracrine BMP activation and limits BMP 
signaling overall in the stomach thus, triggering an increased number of proliferative 
cells and inhibition of terminal differentiation.  
Therefore, these studies provide a molecular explanation for both, terminal 
differentiation of cells in the healthy condition and enhanced plasticity observed in 
gastrointestinal pathologies (Yu et al. 2018; Schwitalla et al. 2013; Stange et al. 2013; 
Tetteh et al. 2016). 
 
4.1 GASTRIC STEM CELLS MICROENVIROMENT UPON H. PYLORI INFECTION 
Gastric glands are characterized by a constant, rapid and highly organized turnover. Role 
of specific epithelial cell types and their responses to H. pylori infection have been widely 
studied. Gao and colleagues have identified hyperproliferation of epithelium (Gao et al. 
2000), Murakami et al. have investigated parietal cell atrophy (Murakami et al. 2013), 
Matsuzwa and colleagues have described increase of gland mucous cells (Matsuzwa et 
al. 2003) and Sigal et al. have shown expansion of stem cells compartment (Sigal et al. 
2015) and its antimicrobial properties (Sigal et al. 2019) upon H. pylori infection. 
However, molecular processes behind these changes still remain not understood. 
In the intestine, mesenchymal cells have been described as crucial cells, which create 
epithelial stem cell niche, providing specific microenvironment signals for different 
types of epithelial cells. As a consequence, they play an essential role in homeostasis 
maintenance as well as in disease development (Roulis and Flavell 2016; Tan and Barker 
2014).  Mesenchymal cells have been reported to express WNT signaling factors such as 
Wnt2b, Wnt4, Wnt5a, Wnt5b and Rspo1, Rspo2 and Rspo3 (Gregorieff et al. 2005; Lei et 
al. 2014). Since Paneth cells are a critical source of canonical WNT signaling in the 
intestine, mesenchymal cells have been suggested to complement this mechanism and 
support non-canonical WNT pathway (Powell et al. 2011). Moreover, they have been 
described as a source of BMP ligands and antagonists. Noggin, GREM1, GREM2 and 
CHRDL1 expression was identified in the crypt base, while BMP4 signal was present in 
the stroma through the whole villi axis and BMP2 expression was limited to the top, but 
also observed in the epithelium (He et al. 2004; Kosinski et al. 2007; Haramis et al. 2004; 
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van Dop et al. 2009). Co-culture experiments showed significant support of epithelial 
organoids growth and development in the presence of mesenchymal cells indicating 
that these cells create microenvironment for epithelial stem cells (Lahar et al. 2011; Lei 
et al. 2014).  Moreover, in vivo studies confirmed significant influence of myofibroblasts 
on goblet and Paneth cells differentiation and thus revealed their role in generation of 
the niche also for differentiated cells (Stzepourginski et al. 2017). Additionally, 
myofibroblasts have been reported as an important factor in intestinal responses to 
tissue injury and bacteria. They are not only responsible for mechanical wound healing 
but also promote compensatory epithelial proliferation by induction of proinflammatory 
tumor progression locus-2 (Tpl2), which promotes arachidonic acid metabolism and 
cyclooxygenase-2 (Cox-2)/prostaglandin E2 activation  (Tomasek et al. 2002; Roulis et al. 
2014).  
Although investigation of myofibroblasts in the small intestine clearly showed their 
essential role in epithelial homeostasis and disease, they have not been well studied in 
stomach. Two independent studies have identified gastric myofibroblasts as the main 
source of RSPO3, which induced expansion of stem cell compartment (Chen et al. 2019; 
Sigal et al. 2017). Moreover, it has been reported that stromal RSPO3 increased upon 
H. pylori infection and induced antimicrobial secretion by Lgr5+ stem cells (Sigal et al. 
2019). Additionally, air liquid interface culture model showed that gastric stromal cells 
of the lamina propria, which are located between, but not beneath, the glands, have not 
supported the epithelial growth and even reduced their stemness (Boccellato et al. 
2018). 
This study applies an unbiased approach to explore the gastric stem cells 
microenvironment in homeostasis and in the context of H. pylori infection. For the first 
time, a mouse model was used to visualize gastric myofibroblasts and identify their 
alterations upon infection. Myh11CreErt2/Rosa26-mTmG mice enabled localization of 
these cells between and beneath the gastric epithelium (Figure 3.1.b) as well as negative 
labeling for EPCAM antibody (Figure 3.2.c). RNAseq from sorted Myh11 cells revealed 
potential role of myofibroblasts in epithelial cells regulation by expressing factors like 
Wnt, Rspo and Bmp (Figure 3.4.b), which is similar to findings in the small intestine 
(Gregorieff et al. 2005; Kosinski et al. 2007). Additionally, infection of mice showed that 
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H. pylori is not only inducing hyperplasia of epithelial cells, but also that Myh11+ 
myofibroblasts population expands upon infection (Figure 3.3.). Further analysis of 
infected myofibroblasts implicates their active role in H. pylori infection by identifying 
significant changes in 197 genes, including strong reduction of BMP ligands and 
induction of BMP inhibitors (Figure 3.4.).  
Exploration of BMP distribution within the tissue demonstrated a spatial gradient similar 
to the one observed in the small intestine with the BMP antagonists in the base of the 
gland and Bmp2 dominant in its top part in both myofibroblasts and epithelial cells 
(Figure 3.5. and 3.6.) (Kosinski et al. 2007; van Dop et al. 2009). Interestingly, Noggin, 
described as the main BMP antagonist present in the base of small intestine crypt, was 
not detected in the mouse stomach glands (Figure 3.6.b) (He et al. 2004). In contrast, 
other Bmp inhibitors such as GREM1/2 and CHRDL1 were present exclusively in the base. 
Gremlins specifically binds BMP ligands and therefore has a similar function to Noggin.  
Boccellato et al. describe that different subtypes of stromal cells have differential effects 
on epithelial proliferation and differentiation. He has observed that stroma from lamina 
propria between the gastric glands reduces epithelial stemness capacity and induces 
differentiation (Boccellato et al. 2018), whereas cells isolated from the base have been 
described as a source of factors inducing stemness (Sigal et al. 2017). My findings on 
spatial distribution of Bmp activators versus inhibitors in myofibroblasts may explain the 
differential influence of subpopulations of stromal cells on epithelial stem cells 
described by Boccellato et al. Gastric stromal cells of the lamina propria used by them 
correspond to cells that I find to be enriched in BMP2 and lack BMP antagonists, which 
enhance stemness.  
Expression of different BMP factors in other parts of gastric gland observed by me and 
expression of Rspo3 limited to basal myofibroblasts described by Sigal et al. (Sigal et al. 
2017) indicate different stroma populations in the top and in the base of gastric gland. 
These findings are consistent with observation reported in the small intestine, which 
distinguished basal cell population enriched in Wnt2b, Grem1 and Rspo1 and stroma 
population in the villus region expressing Bmp2, Bmp7, Ptch1 and Acta2  (Stzepourginski 
et al. 2017). Finally, I was able to confirm RNAseq results by ISH and show up-regulation 
of Grem1, Grem2 and Chrdl1 in the myofibroblasts compartment and strong down-
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regulation of Bmp2 in the upper parts of gland within the tissue upon infection (Figure 
3.7. and 3.8.), which provides another evidence of their active response to H. pylori 
infection. Thus, this study is the first to describe the spatial distribution of BMP-
associated molecules in myofibroblasts and their changes upon H. pylori infection. 
 
4.2 ROLE OF BMP SIGNALING IN EPITHELIAL DIFFERENTIATION 
BMP pathway has been reported to play an essential role in growth and differentiation 
of the developing gastrointestinal tract as an coordinator of endodermal and 
ectodermal patterning (Batts et al. 2006). In the stomach development it is responsible 
for regionalization of specific stomach regions and KO of BMP receptor leads to increase 
of the forestomach at the expense of the corpus part (Maloum et al. 2011). Moreover, 
BMP is required for establishment of the pyloric sphincter and its deletion in both 
mesenchymal and endoderm layers leads to impaired pyloric sphincter formation (Smith 
et al. 2000; Smith and Tabin 1999; Zhang and Que 2019). 
In the adult, developed stomach BMP signaling has been identified as a crucial pathway. 
Inhibition of BMP signaling in different cell types in the murine stomach results in 
increase of gland height, hyperproliferation, loss of parietal cells, increased number of 
cells expressing GSII, formation of cystic structures and even induction of CD44 and C-
Myc expression, which are involved in gastric carcinogenesis (Shinohara et al. 2010; Ye 
et al. 2018; Takabayashi et al. 2014). However, most of the studies induced alteration in 
BMP signaling in selected cells and focus on specific responses in this compartment. 
Therefore, in this study, to create a systematic picture of the function of BMP signaling, 
I performed 3D organoid cultures with BMP ligands and inhibitors and investigated 
alterations in gene expression of markers characteristic for all antral gland cell types. 
These experiments clearly showed BMP as a factor which promotes differentiation into 
surface mucous cells and reduces expression of basal markers as well as inhibition of 
proliferation (Figure 3.9.). This is consistent with previous in vivo observations, which 
identified hyperplasia, hyperproliferation, loss of surface mucous cells and induction of 
mucous neck cells in stomach with overexpression of BMP inhibitor Noggin or inhibition 
of BMPR1a in both mesenchymal and epithelial cells (Maloum et al. 2011; Roy et al. 
2016; Todisco et al. 2015). However, I did not observe any changes in expression of 
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enteroendocrine markers like Chga or Gast upon BMP treatment or inhibition, which has 
been identified in the corpus with Bmpr1a KO (Maloum et al. 2011). The difference may 
be due to investigation of different regions of stomach or involvement of some other 
signaling, which can be limited during in vitro cultures. Moreover, organoids 
experiments revealed Lgr5+ stem cell inhibition by BMP ligands that has been widely 
examined in the small intestine and not fully explored in the stomach (Qi et al. 2017; Ye 
et al. 2018). Studies from small intestine have shown direct suppression of Lgr5+ stem 
cell signature genes, but not WNT target genes such as Axin2, by BMP activation, which 
can be reversed by BMP inhibitors (Qi et al. 2017). This observation is consistent with 
Lgr5 down-regulation in organoids upon BMP2 and BMP4 treatment, which was re-
induced by BMP inhibitors as well as no changes in Axin2 expression upon indicated 
treatments (Figure 3.9.c-d). Furthermore, as a confirmation of these findings, 
experiments performed in the stomach presented Lgr5 induction in mice with Bmpr1a 
KO or Noggin overexpression under the Lgr5 promotor (Ye et al. 2018).  
Additionally, I discovered that factors, which regulate Bmp2 expression in the 
epithelium are BMP ligands themselves (Figure 3.14.a). Experiments involving organoids 
showed reduction of growth, stemness, basal identity and induction of differentiation 
into surface mucous cells with concentration of BMP2 sufficient to induce Bmp2 
expression (Figure 3.14.b-c). This indicates the presence of BMP2 auto-paracrine loop, 
which, referring to Bmp distribution and function, maintains and enhances BMP 
signaling-driven differentiation of the epithelial cells on their way to the surface. BMP2 
auto-paracrine loop may explain epithelial hyperplasia observed in mice with BMP 
signaling inhibition not only in epithelial cells but also in stromal cells. Inhibition of Bmp2 
in either cell type could lead to loss of positive feedback loop, lower level of Bmp 
signaling and therefore increased proliferation and reduced differentiation (Roy et al. 
2016; Shinohara et al. 2010). I could demonstrate how BMP signaling is self-enhanced 
and stabilized in the surface through Bmp2 autocrine loop. Investigations of 
maintenance of BMP gradient have not been done in the healthy gastrointestinal tract. 
However, data from colon have shown similar regulatory pathway: Bmp4 expression 
was reduced by the inhibition of BMP signaling in colorectal cancer, indicating that BMP 
forward loops may be a general mechanism (Yokoyama et al. 2017).  
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Since WNT signaling is inducing proliferation, reducing differentiation and also creates 
the gradient within the gastric gland (which is opposite to BMP with high WNT in the 
base and low WNT in the surface), it has been suggested as a driver of gastric gland 
turnover (Fischer and Sigal 2019). Therefore, I compared the influence of WNT and BMP 
pathways on epithelial differentiation, proliferation and stemness by culturing gastric 
epithelial organoids with BMP signaling induction or WNT signaling reduction. 
Experiments showed that both conditions are inhibiting proliferation and growth of the 
organoids and both conditions are sufficient to block expression of gland base cell 
markers and induce differentiation into surface mucous cells (Figure 3.12.). However, 
changes caused by BMP activation were much stronger and irreversible. BMP treatment 
induced terminal differentiation and led to complete loss of stemness properties in 
cultured organoids (Figure 3.13.), which indicates that BMP is a main driver of gastric 
gland turnover. These results are consistent with observation made in the small 
intestine by Qi and colleagues (Qi et al. 2017). They have reported that BMP signaling 
suppresses expression of stem cells signature independently of WNT signaling by 
SMAD4 protein, which directly regulates promotor of these cells. On the other side, air 
liquid interface culture of gastric epithelium showed that WNT signaling can drive 
differentiation from MUC6+ to MUC5AC+ cells (Boccellato et al. 2018). It was confirmed 
in vivo by identifying WNT co-mediator RSPO3 as a crucial factor regulating stem cells 
compartment, promoting expression of basal markers and inhibiting differentiation into 
surface mucous cells (Sigal et al. 2017; Sigal et al. 2019). Although Rspo3 in vivo KO and 
in vitro withdrawal led to reduction of stem cell compartment, RSPO3 injection into the 
tissue was sufficient to induce only Axin2+ stem cells, but not Lgr5+ cells, indicating that 
there has to be another pathway regulating this compartment. This now can be 
explained by the identified BMP gradient, which inhibits particularly Lgr5+ cells, but not 
Axin2+ cells. Therefore, even when WNT signaling is induced in the Lgr5+ cells, they are 
still limited to the niche enriched by BMP inhibitors and cannot expand to the BMP2+ 
compartment.  
While recent data suggest that BMP and WNT signaling act independently on expression 
of stem cell associated genes such as Lgr5 on cellular signaling level, I found that BMP 
pathway regulates expression of stromal Rspo3. RSPO3, an essential regulator of WNT 
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signaling in the stomach described by Sigal et al., has its source in myofibroblasts located 
beneath the glands (Sigal et al. 2017). Culture of the myofibroblasts isolated from the 
entire antrum (including subpopulations from beneath the gland as well as 
intraglandular cells) revealed that their expression of Rspo3 is reduced upon BMP 
activation and is induced with BMP inhibition (Figure 3.16.). These results suggest that 
Rspo3 is limited to the basal myofibroblasts, because it is suppressed elsewhere by BMP 
signaling and can be only expressed in the niche lacking BMP signaling. Moreover, its 
induction and expansion from the base to the stroma along the gland axis, which is 
observed upon H. pylori infection, may be explained by decreasing BMP gradient (Figure 
3.7. and 3.8.) (Sigal et al. 2017). Taken together I could identify multiple intercellular 
communication routes that guide epithelial proliferation and differentiation, including 
an induction of a paracrine and autocrine Bmp feed forward loop that not only stabilizes 
epithelial differentiation but also blocks opposing stromal signals such as Rspo3 
expression.  
 
4.3 IFNγ INTERACTIONS WITH BMP SIGNALING 
Infection with H. pylori induces changes in gland organization which further leads to 
gastric pathologies and even cancer (Correa and Piazuelo 2012). Since BMP2 signaling 
was identified as a main driver of gastric gland differentiation and its expression changed 
upon infection, its regulation in the context of infection was analyzed. The results 
revealed that inhibition of Bmp2 expression and subsequent hyperproliferation and 
hyperplasia upon infection depend on functional H. pylori T4SS (Figure 3.17.a-c), which 
is consistent with previous data that reported less severe gastric pathology evoked by 
strains lacking the cagPAI pathogenicity island compared to wildtype H. pylori (Sigal et 
al. 2015). Furthermore, functional T4SS has been demonstrated to be required to induce 
a recruitment of proinflammatory subsets of immune cells to the site of the infection 
(Arnold, Lee, et al. 2011). These cells, particularly Th1 cells, are mostly producing IFNγ 
as a response to the infection (Smythies et al. 2000). Consistently, my results showed 
that IFNγ and IFNγ target genes are highly upregulated upon H. pylori infection and that 
IFNγ induction is much lower in mice infected with mutants in the functional T4SS 
(Figure 3.17.d-e). 
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IFNγ function analysis with organoid model revealed its inhibitory effect on BMP 
signaling, which was obtained even with small concentrations of the protein. It did not 
only reduce the expression of overall BMP target gene Id1 by half, but also strongly 
decreased expression of Bmp2 itself (Figure 3.18.a-c). Microarray analysis confirmed 
these results and showed significant inhibition of BMP2 targets and induction of genes 
identified as down-regulated BMP2 targets in organoids treated with IFNγ (Figure 
3.18.d-e). These data may explain the previously described gastric phenotypes induced 
by IFNγ, described by scientists: Sayi and colleagues have identified IFNγ as a factor 
responsible for induction of chronic inflammation, hyperplasia and atrophy upon H. 
pylori infection. Using IFNy-deficient mice, they have not observed any of these 
pathological changes (Sayi et al. 2009). Additionally, Zuo et al. performed the opposite 
experiment, in which they injected recombinant IFNγ into the mice for 21 days and have 
reported epithelial hyperproliferation and atrophy (Zuo et al. 2019). These findings may 
be explained by changes in BMP signaling induced by IFNγ: IFNγ KO mice should not have 
any changes in Bmp2 expression, whereas injection of IFNy should induce loss of BMP 
signaling and loss of Bmp2 expression. Indeed, effects of Bmp KO on gastric epithelial 
pathology appear to be resembled by IFNγ injection into mice. 
Not only hyperplasia has been identified as an IFNγ-induced alteration of epithelial 
organization in the stomach. It has been reported that IFNγ is inducing gastric mucous 
neck cells hypertrophy and suppression of Muc5ac expression (Kang et al. 2005; Oyanagi 
et al. 2017). Additionally, in the small intestine IFNγ treatment results in release of 
antimicrobial products by Paneth cells (Farin et al. 2014). These observations inversely 
correlate with BMP function described here, which showed differentiation into Muc5ac+ 
cells, inhibition of basal markers and antimicrobial genes expressed by them upon BMP 
treatment (Figure 3.9. and 3.11.). Therefore, it is likely that the previously described IFNγ 
dependent phenotypes are mediated via reduction in BMP signaling. Further 
experiments would be required to determinate interactions between IFNγ and BMP 
signaling and specific role of IFNγ in different gastric cell types. For example, 
investigation of Bmp2 expression upon depletion of IFNγ specifically in the epithelium. 
Moreover, the effect of the IFNγ on stromal BMP signaling requires further attention.  
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Since BMP signaling inhibits proliferation and IFNγ is reducing BMP, I expected that 
addition of IFNγ to the organoid culture will improve their growth and development. 
However, number of organoids cultured with recombinant IFNγ was smaller compared 
to untreated control (Figure 3.19.a). This was consistent with observations reported by 
others, which described organoid cell apoptosis upon IFNγ treatment and overall anti-
proliferative character of IFNγ (Osaki et al. 2019; Schroder et al. 2004). Lineage tracing 
for Lgr5+ stem cells performed in this study revealed that more organoids created upon 
IFNγ treatment are deriving from Lgr5-negative cells compared to untreated controls, 
suggesting the involvement of some other cell type (Figure 3.19.b). Therefore, to identify 
these cells, I decided to investigate IFNγ influence on cells differentiated by BMP2 and 
found that although IFNγ is inhibiting proliferation in stem cells, it appears to block 
terminal differentiation induced by BMPs, allowing recruitment of differentiating cells 
to the stem cell pool once exposed to stem cell signals (Figure 3.19.c-d). These results 
appear to be consistent to observations described in the murine stomach, which have 
shown induction of quiescence of multi-lineage progenitors upon IFNγ administration 
(Qiao et al. 2007). Moreover, it also provides an explanation for reported hyperplasia 
upon IFNγ treatment and its absence in IFNγ-deficient mice despite IFNγ anti-
proliferative role (Sayi et al. 2009; Zuo et al. 2019). While IFNγ does not promote 
proliferation itself, it enhances the plasticity and extends pool of cells able to respond 
to pro-proliferative signals. Thus, these observations indicate a mechanism of epithelial 
re-arrangements upon H. pylori, which is driven by IFN-y that blocks BMP2-driven 
terminal differentiation, thereby preserves plasticity in differentiating cells, finally 
resulting in hyperplasia, hyperproliferation, induction of basal and inhibition of surface 
cells (Figure 3.3. and 3.10.). However, some further in vivo experiments, for example 
with transgenic IFNγKO mice, are required to confirm these findings.  
 
4.4 TISSUE ADAPTATION TO INFECTION AND CANCER PHENOTYPE 
Gastric cancer development has been described as a process reflected by histological 
changes, termed Correa’s cascade. This describes changes from normal gastric mucosa 
to chronic gastritis, atrophy, intestinal metaplasia, dysplasia and finally gastric cancer 
(Correa 1992; Correa and Piazuelo 2012). H. pylori has been identified as a factor 
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inducing inflammation, which leads to hyperplastic gastritis, atrophy and metaplasia 
(Sigal et al. 2015; Weck and Brenner 2008; Byrd and Bresalier 2000). Here, I identified 
IFNγ as a main regulator of epithelial organization and found that one of its effects is the 
inhibition of BMP signaling (Figure 3.18.). This Thesis has shown that BMP signaling 
directs differentiation of gastric epithelial cells into highly differentiated pit surface 
mucous cells (Figure 3.9.).  
These observations provide new mechanistic links between infection, inflammation and 
epithelial homeostasis. Hyperproliferation and hyperplasia observed upon H. pylori 
infection (Abraham et al. 2001; Sigal et al. 2015) may be the result of BMP signaling 
inhibition via IFNγ (Figure 3.17 and 3.18.). Atrophy, which describes the loss of 
differentiated cells, as a second step of Correa’s cascade (Kuipers et al. 1997) can be 
explained by impaired differentiation as a result of IFNγ-driven inhibition  of terminal 
differentiation (Figure 3.19.). Moreover, infection with H. pylori has been correlated 
with disturbed mucus production: reduction of pit surface mucous producing cells and 
hypertrophy of mucous neck cells (Byrd and Bresalier 2000). Loss of pit surface mucous 
producing cells is the characteristic feature of intestinal metaplasia (Park et al. 2015), 
whereas expression of mucous neck cells in dysplastic lesions has been identified as a 
predictor for malignant progression (Marin et al. 2012). These findings may be also 
explained by the impaired BMP signaling upon infection, which regulates proper 
differentiation into pit surface mucous cells and inhibits expression of mucous neck cells 
during homeostasis (Figure 3.9.).  
Taken together, my results suggest that BMP signaling reduction by IFNγ upon H. pylori 
infection contributes to development of premalignant lesions, such as hyperplasia, 
atrophy and metaplasia. Loss of differentiated cells and expansion of stem and 
progenitor cells upon infection may lead to a disrupter barrier and enhanced exposure 
of stem cells towards the potentially toxic luminal content in the stomach, which may 
not only lead to direct genomic damage in stem cells but also further perpetuate the 
inflammatory cascade overall enhancing the risk for development of gastric cancer.  
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4.5 OUTLOOK 
These studies highlight a mechanism related to the molecular communication between 
inflammation and epithelial organization. The observations may not be limited to 
stomach and H. pylori infection but rather have broader implications. Accordingly, 
impaired differentiation appears to be a hallmark of inflammation in the whole 
gastrointestinal tract. Studies have reported loss of goblet cells in both colon during 
ulcerative colitis and small intestine during inflammatory bowel disease as well as loss 
of secretory cells in the stomach with infection or inflammatory conditions (Parker et al. 
2019; Gersemann et al. 2009; Peek et al. 1997). Moreover, alternations in differentiation 
during inflammation refer not only to cell loss but also to enhanced plasticity. Injury in 
the colon leads to repopulation of the crypts by highly differentiated Atoh1+ and Krt20+ 
cells (Castillo-Azofeifa et al. 2019; Harnack et al. 2019). Irradiation of the small intestine 
is inducing proliferation and multipotency in mature Paneth cells as well as injury in the 
Alpi+ enterocytes (Yu et al. 2018; Tetteh et al. 2016). Even in the stomach, quiescent 
Troy+ chief cells have been reported to replenish entire gastric units upon tissue damage 
(Stange et al. 2013). These observations have shown that also in other organs upon 
inflammation stem cells properties are induced in highly differentiated cells. Together 
with the fact that BMP signaling is present in all organs and results showing BMP-driven 
differentiation mechanism presented in these studies, it suggests the potential role of 
BMP pathway as universal regulatory principle of tissue plasticity apart from classical 
inflammatory triggers in the entire gastrointestinal tract. Therefore, exploration of BMP 
signaling in context of the inflammation in different organs of the gastrointestinal tract 
will be important for generalizing based on my observations. 
Furthermore, the involvement of H. pylori in gastric cancer development paired with the 
prominent regulatory function of BMP signaling in epithelial re-organization upon 
infection may implicate BMP involvement in cancer development. Respective 
observations from colon studies indeed revealed a strong reduction of BMP2 in cancer 
samples (Vishnubalaji et al. 2016). Moreover, the facts that in vitro re-expression of 
Bmp2 in cancer cell lines led to inhibition of cell growth and increased chemosensitivity 
and that overexpression of Bmp2 in vivo inhibited tumor formation suggests BMP2 is a 
critical suppressor of tumorigenesis, probably due to its effects on differentiation. It 
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implies that targeting Bmp2 could be used as a therapeutic strategy (Vishnubalaji et al. 
2016). On the other hand, BMP7, which was not detected here in the normal 
homeostatic stomach, has been reported as a potential predictor of risk of tumor 
recurrence in gastric cancer (Aoki et al. 2011). Additionally, KO of Bmpr1a in gastric 
mesenchyme resulted in the induction of reactive mesenchyme, which expressed 
Cancer-Associated-Fibroblasts markers (Roy et al. 2016). Finally, studies from stomach 
addressing the role of BMP2 in gastric cancer cell lines indicated dual functions of BMP2 
as both promotor and suppressor of the cancer (Kang et al. 2011; Zhang et al. 2012). 
Thus, the important role of BMP signaling in gland turnover, its alterations in chronic 
inflammation and its effects on gastric cancer cell lines are calling for further 
investigations on the role of BMP pathway in development of gastric cancer.  
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List of abbreviations 
Quantities and units were abbreviated according to the International System of Units. 
2D  two-dimensional  
3D  three-dimensional  
4-OHT  4-hydroxytamoxifen 
ACTR 1A/2A/2B activin receptor type 1A/2A/2B 
ADF  advanced DMEM/F12 
ADP adenozyno-5′-difosforan 
ADP heptose ADP-glycero-β-D-manno-heptose 
AKT protein kinase B 
ALPK 1 alpha kinase 1 
AMP 1/2/3/4/5/6 RNAscope amplification solution 
AP1 activator protein 1 
APC  antigen-presenting cells  
ATP adenosine triphosphate 
ATP4b ATPase H+/K+ transporting subunit beta 
AXIN2 axis inhibition protein 2 
BHI brain heart infusion 
BLAST  basic local alignment search tool  
BMP  bone morphogenetic protein  
BMPR 1A/1B/2 bone morphogenetic protein receptor type 1A/1B/2 
bp  base pair  
BSA  bovine serum albumin  
Ca calcium 
Cag A/E/PAI  cytotoxin-associated gene A/E/pathogenicity island 
CCKBR cholecystokinin B receptor 
CDK1  cyclin-dependent kinase 1  
cDNA complementary DNA 
CFU  colony forming unit  
CGT cholesterol-a-glucosyltransferase 
CHGA chromogranin A 
CHO  chinese hamster ovary  
CHRD chordin 
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CHRDL1 chordin like 1 
CO2 carbon dioxide 
COX 2 cyclooxygenase 2 
CRC colorectal cancer  
CRE cyclization recombinase 
CRIM cysteine rich transmembrane BMP regulator 1 
cRNA complementary RNA 
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mRNA messenger RNA 
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qRT-PCR quantitative reverse transcription polymerase chain reaction  
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α-SMA  α smooth muscle actin  
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